data_5xk5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5xk5 _Structure_validation_residue.Date_analyzed 2017-06-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.526 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.526 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 23' ' ' ILE . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.3 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 23' ' ' ILE . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 23' ' ' ILE . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.649 ' NH2' ' HH ' ' A' ' 59' ' ' TYR . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.7 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 44' ' ' ILE . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 36' ' ' ILE . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 9' ' ' THR . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.56 ' H ' ' HG1' ' A' ' 7' ' ' THR . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.8 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 36' ' ' ILE . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 17' ' ' VAL . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 36' ' ' ILE . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 23' ' ' ILE . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' NH2' HE22 ' A' ' 49' ' ' GLN . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.5 HE22 ' NH2' ' A' ' 42' ' ' ARG . 35.0 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.937 0.398 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 23' ' ' ILE . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.5 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.485 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.891 0.377 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.578 ' HG1' ' ND2' ' A' ' 25' ' ' ASN . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HG1' ' A' ' 22' ' ' THR . 70.9 m-20 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 44' ' ' ILE . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 14.8 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.1 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.934 0.397 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' ' CG ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.465 ' H ' ' HG1' ' A' ' 14' ' ' THR . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.558 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.558 ' H ' ' HG1' ' A' ' 22' ' ' THR . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 30' ' ' ILE . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.648 ' ND2' HE22 ' A' ' 62' ' ' GLN . 27.1 t30 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.648 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.686 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.686 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 23' ' ' ILE . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.647 ' H ' ' HG1' ' A' ' 22' ' ' THR . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.0 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.419 HH21 ' NE2' ' A' ' 49' ' ' GLN . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 44' ' ' ILE . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' NE2' HH21 ' A' ' 42' ' ' ARG . 37.0 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 58' ' ' ASP . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 55' ' ' THR . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.64 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 31.1 t30 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HZ2' HD22 ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 30' ' ' ILE . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.515 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.515 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 36' ' ' ILE . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 44' ' ' ILE . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.902 0.382 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 36' ' ' ILE . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 23' ' ' ILE . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.506 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.506 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 23' ' ' ILE . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.63 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.63 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.664 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 30' ' ' ILE . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.92 0.391 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' GLY . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' CG2' HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.412 HE22 ' CG2' ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.9 0.381 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.8 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 23' ' ' ILE . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' H ' ' HG1' ' A' ' 22' ' ' THR . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 36' ' ' ILE . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.576 ' NH2' ' HH ' ' A' ' 59' ' ' TYR . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.0 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.525 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.639 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.638 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.638 ' H ' ' HG1' ' A' ' 22' ' ' THR . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.452 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HZ1' ' CG2' ' A' ' 66' ' ' THR . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 36' ' ' ILE . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 44' ' ' ILE . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HG ' ' N ' ' A' ' 58' ' ' ASP . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' N ' ' HG ' ' A' ' 57' ' ' SER . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HZ1' ' A' ' 6' ' ' LYS . 39.1 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 23' ' ' ILE . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 30' ' ' ILE . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.526 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.526 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 23' ' ' ILE . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.3 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.45 68.0 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m -99.88 120.07 39.2 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.891 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.9 t -106.74 143.11 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.17 -175.53 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.556 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -58.65 -50.28 74.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.218 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.0 mt -69.79 132.49 46.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -61.09 -41.15 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.95 -169.27 42.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.743 0 CA-C-O 117.971 -1.461 . . . . 0.0 110.99 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 23' ' ' ILE . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 58.04 68.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -99.74 125.01 45.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.854 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.5 140.42 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 172.93 6.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -64.32 -52.0 60.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.63 125.34 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 54.84 28.48 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.03 -55.25 30.71 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.961 -1.466 . . . . 0.0 110.867 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 23' ' ' ILE . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 72' ' ' ARG . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.649 ' NH2' ' HH ' ' A' ' 59' ' ' TYR . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 58.88 69.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m -99.66 123.29 43.78 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.75 142.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.515 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -70.24 179.9 2.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.052 0.453 . . . . 0.0 110.476 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 40' ' ' GLN . 46.7 ttp180 -48.52 -49.38 36.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.17 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -83.33 146.55 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.351 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -72.22 136.18 46.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.506 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.16 -69.69 1.25 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.798 -179.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.7 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 58.05 68.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.9 m -100.03 123.18 43.98 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.03 153.33 36.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.84 171.94 7.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.067 0.46 . . . . 0.0 110.464 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -77.24 -45.63 25.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 73' ' ' LEU . 9.9 mp -70.22 162.22 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -168.47 -68.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.524 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.75 -46.45 0.26 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 CA-C-O 117.989 -1.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 44' ' ' ILE . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 56.72 63.17 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -131.05 136.37 48.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.62 149.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.18 172.17 8.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.029 0.443 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -66.48 -38.78 88.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.38 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.98 72.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.062 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -62.33 -17.91 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.3 66.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.907 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 36' ' ' ILE . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 58.2 68.44 0.83 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -103.4 121.9 43.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 t -116.33 145.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.07 175.18 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.454 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -70.38 -42.77 71.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.26 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.52 69.92 5.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.273 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 -55.61 139.42 44.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 -30.26 5.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.864 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 9' ' ' THR . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.56 ' H ' ' HG1' ' A' ' 7' ' ' THR . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.8 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 36' ' ' ILE . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' O1P' ' A' ' 65' ' ' SEP . 43.0 mt-10 58.48 69.38 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.424 ' O1P' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m -104.5 118.98 37.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.57 144.88 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.66 170.98 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.525 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -58.78 -47.0 86.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.168 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 tp 50.9 99.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.281 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -70.14 133.7 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.21 -66.9 2.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.98 -1.456 . . . . 0.0 110.849 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 17' ' ' VAL . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 36' ' ' ILE . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 58.38 69.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m -101.27 122.74 44.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.676 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.21 142.22 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 3.0 mm? -84.36 177.61 8.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -59.99 -50.86 72.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.959 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 tp -90.19 122.52 33.21 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.34 164.22 23.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.62 34.75 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.009 -1.439 . . . . 0.0 110.866 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 23' ' ' ILE . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' NH2' HE22 ' A' ' 49' ' ' GLN . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.5 HE22 ' NH2' ' A' ' 42' ' ' ARG . 35.0 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 58.41 68.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m -102.1 122.57 44.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.88 146.22 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.11 -176.69 6.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -64.27 -44.15 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 7.1 mp -78.09 108.1 11.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.286 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -65.73 -75.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 167.86 28.38 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 CA-C-O 117.923 -1.487 . . . . 0.0 110.818 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 23' ' ' ILE . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.5 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.485 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.46 67.68 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -97.38 120.76 38.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.711 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t -110.95 142.4 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -122.53 172.92 8.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 110.869 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -63.96 -53.54 48.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.414 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 8.6 mp -70.23 102.94 2.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -66.41 -38.18 86.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.09 -132.89 24.02 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.756 0 CA-C-O 117.958 -1.468 . . . . 0.0 110.94 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HG1' ' ND2' ' A' ' 25' ' ' ASN . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' HG1' ' A' ' 22' ' ' THR . 70.9 m-20 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 44' ' ' ILE . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 14.8 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.1 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 57.19 68.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -99.76 123.89 44.48 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.617 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.3 144.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 171.93 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 0.0 110.414 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -67.29 -48.56 67.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.02 90.4 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.436 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.77 -47.18 86.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.661 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -127.29 1.29 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.998 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' ' CG ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.465 ' H ' ' HG1' ' A' ' 14' ' ' THR . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.558 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.558 ' H ' ' HG1' ' A' ' 22' ' ' THR . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 30' ' ' ILE . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.648 ' ND2' HE22 ' A' ' 62' ' ' GLN . 27.1 t30 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.648 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 57.25 68.99 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -98.95 119.46 37.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.67 140.09 22.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.55 171.94 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.7 -49.27 63.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.381 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 8.4 mp -66.42 137.84 57.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.229 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 51.87 18.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.36 -21.94 72.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.979 -1.456 . . . . 0.0 110.877 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.686 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.686 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 23' ' ' ILE . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.647 ' H ' ' HG1' ' A' ' 22' ' ' THR . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.0 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' ARG . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.419 HH21 ' NE2' ' A' ' 49' ' ' GLN . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 44' ' ' ILE . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' NE2' HH21 ' A' ' 42' ' ' ARG . 37.0 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 58' ' ' ASP . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 55' ' ' THR . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 58.07 69.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m -102.17 122.82 44.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.37 145.53 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.39 -175.7 5.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' GLN . 50.8 ttt85 -54.75 -46.3 74.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.304 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.78 125.6 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.235 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -62.29 -36.7 82.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.739 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.29 -107.43 0.67 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.815 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.64 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 31.1 t30 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HZ2' HD22 ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 30' ' ' ILE . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.35 68.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -101.66 120.58 40.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.752 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.37 146.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mt -72.01 -175.47 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.525 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -64.08 -21.62 66.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -71.71 121.89 19.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -79.0 -28.59 43.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.04 114.59 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.8 0 CA-C-O 118.047 -1.418 . . . . 0.0 110.92 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.515 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.515 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 57.23 68.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -96.96 122.07 39.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.85 139.42 23.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -86.35 173.6 9.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.173 0.511 . . . . 0.0 110.328 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -55.97 -13.97 2.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tp 59.26 62.93 1.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.213 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -62.76 -40.28 96.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.799 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.21 -149.13 17.05 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.899 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 36' ' ' ILE . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 44' ' ' ILE . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 57.03 67.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -101.29 121.02 41.13 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.713 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.24 142.67 19.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.43 166.27 13.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.089 0.471 . . . . 0.0 110.521 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -85.82 -56.27 3.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -169.16 106.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -61.48 -49.21 77.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.5 -100.15 0.14 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.976 -1.458 . . . . 0.0 110.896 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 36' ' ' ILE . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 58.62 69.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -100.71 122.0 42.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -108.15 141.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 166.26 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -80.43 -38.55 29.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.243 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -84.4 60.33 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.302 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -69.07 -27.06 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.03 141.08 27.61 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.023 -1.432 . . . . 0.0 110.89 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 23' ' ' ILE . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 58.13 69.56 0.72 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -103.05 127.31 50.35 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -107.9 141.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.37 175.94 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.48 . . . . 0.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -67.29 -41.01 86.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -83.96 77.34 9.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.256 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -56.6 -33.05 65.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.887 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.9 -141.29 48.16 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.758 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.892 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.506 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 23' ' ' ILE . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.44 69.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m -98.53 121.77 40.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.11 150.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.75 -175.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 73' ' ' LEU . 16.9 ptm180 -56.5 -24.62 47.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.265 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 72' ' ' ARG . 5.2 mp 47.12 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 46.47 83.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.14 -137.7 2.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 118.046 -1.419 . . . . 0.0 110.94 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.63 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.63 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 58.71 69.73 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -104.04 125.03 50.08 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.21 143.88 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.11 -175.65 4.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.43 -40.92 72.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.76 131.53 39.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.357 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -64.13 -42.06 96.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.65 164.41 34.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.94 -1.478 . . . . 0.0 110.924 179.899 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.664 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 57.1 69.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m -99.16 120.21 39.13 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.432 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.07 152.39 36.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.87 -176.44 6.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.692 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -77.01 -56.41 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.3 -15.38 53.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.999 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 54.31 87.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.12 -67.68 0.08 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.026 -0.829 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.006 -1.441 . . . . 0.0 110.954 179.989 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 30' ' ' ILE . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' OD1' ' NH1' ' A' ' 72' ' ' ARG . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 58.93 68.42 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -100.3 122.74 43.57 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.68 150.05 27.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.62 -177.23 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.756 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' NH1' ' OD1' ' A' ' 39' ' ' ASP . 36.8 ttm180 -70.83 -38.79 73.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.41 130.95 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -71.37 120.59 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.479 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.03 80.88 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.077 -1.401 . . . . 0.0 110.872 179.926 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.448 HG21 ' H ' ' A' ' 65' ' ' SEP . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' GLY . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' CG2' HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.412 HE22 ' CG2' ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.59 69.1 0.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.448 ' H ' HG21 ' A' ' 3' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 m -99.8 124.56 45.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.713 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.89 138.88 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mt -78.6 -175.68 4.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.591 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -61.76 -38.14 86.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 10.2 mp -61.99 143.56 56.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.049 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.52 129.12 38.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 53.98 -102.98 0.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.9 -179.832 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.8 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 58.03 68.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m -101.93 122.08 43.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.62 140.11 25.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.23 171.02 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 110.391 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.67 -49.69 76.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt 65.65 107.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.101 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -70.18 131.93 45.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.793 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.68 73.85 0.61 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.933 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 23' ' ' ILE . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' H ' ' HG1' ' A' ' 22' ' ' THR . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 36' ' ' ILE . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 57.41 66.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m -101.97 126.11 48.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t -110.32 143.56 20.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.15 170.59 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.207 0.527 . . . . 0.0 110.467 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -86.51 -50.12 7.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.322 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -160.12 178.3 9.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -157.32 161.84 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.576 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.41 -77.02 0.15 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.966 -1.463 . . . . 0.0 110.841 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.576 ' NH2' ' HH ' ' A' ' 59' ' ' TYR . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 58.25 69.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m -98.98 122.95 42.91 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.26 143.28 20.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.659 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.3 pt? -92.48 174.45 7.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.57 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -54.9 -52.55 62.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.35 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 57.2 tp -71.74 136.03 47.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.257 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -148.82 156.92 43.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.62 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.49 -178.55 53.64 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.924 -1.486 . . . . 0.0 110.812 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.0 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.639 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 57.3 68.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -103.09 120.13 40.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.42 144.87 18.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.87 162.12 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 110.417 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -85.89 -62.08 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.069 179.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.3 mt -107.74 145.46 33.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.224 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -55.94 -36.62 67.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.747 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.74 132.97 1.52 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 117.952 -1.471 . . . . 0.0 111.01 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.638 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.638 ' H ' ' HG1' ' A' ' 22' ' ' THR . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.452 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 57.88 68.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -97.37 121.98 39.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.29 151.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.8 -178.07 5.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -77.73 -41.33 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.227 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 tp 57.11 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.01 -40.44 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.45 18.86 72.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.013 -1.437 . . . . 0.0 110.954 -179.893 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HZ1' ' CG2' ' A' ' 66' ' ' THR . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 36' ' ' ILE . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 44' ' ' ILE . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HG ' ' N ' ' A' ' 58' ' ' ASP . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' N ' ' HG ' ' A' ' 57' ' ' SER . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 58.43 69.39 0.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 ' CG2' ' HZ1' ' A' ' 6' ' ' LYS . 39.1 m -101.19 121.82 42.53 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.61 142.11 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.53 170.4 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.117 0.484 . . . . 0.0 110.408 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -62.06 -16.27 50.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.355 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.77 37.86 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.6 91.36 7.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.424 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.47 161.21 25.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 23' ' ' ILE . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 30' ' ' ILE . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.56 65.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 121.88 38.39 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.679 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.04 148.31 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -72.4 -175.61 1.63 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -47.58 -34.0 7.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 9.8 mp -62.7 146.42 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.92 151.56 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.755 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.7 -33.76 35.04 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.022 -1.432 . . . . 0.0 110.922 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 3' ' ' ILE . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 15' ' ' LEU . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 14' ' ' THR . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.4 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD23 ' A' ' 69' ' ' LEU . 49.9 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HZ2' ' HG ' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HG ' ' HZ2' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.6 t . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' ILE . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 15' ' ' LEU . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 14' ' ' THR . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.412 ' N ' HD23 ' A' ' 69' ' ' LEU . 95.3 t . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HD12 ' A' ' 15' ' ' LEU . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 14' ' ' THR . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 1.1 p-10 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' HD22 ' A' ' 67' ' ' LEU . 89.9 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.1 p . . . . . 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 69' ' ' LEU . 39.1 t . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' ILE . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.439 ' O ' HD12 ' A' ' 15' ' ' LEU . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 14' ' ' THR . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG21 HE22 ' A' ' 41' ' ' GLN . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HG21 ' A' ' 30' ' ' ILE . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 41' ' ' GLN . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.3 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 43.9 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.4 t . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 3' ' ' ILE . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.591 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.937 0.398 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.0 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.8 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.521 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' OE1' ' A' ' 41' ' ' GLN . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.891 0.377 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 14.1 m120 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' C ' HE22 ' A' ' 62' ' ' GLN . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.51 HE22 ' C ' ' A' ' 60' ' ' ASN . 24.6 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.934 0.397 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD12 ' A' ' 44' ' ' ILE . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' NE2' ' A' ' 62' ' ' GLN . 25.5 t-20 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' CD ' ' N ' ' A' ' 62' ' ' GLN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.407 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.2 t . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.3 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.9 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.6 t-20 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.4 t . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 3' ' ' ILE . 33.1 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.902 0.382 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.8 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 3' ' ' ILE . 82.3 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.449 ' C ' HD22 ' A' ' 67' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.499 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.0 m . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.517 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 14' ' ' THR . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.9 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 23' ' ' ILE . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 14' ' ' THR . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 17' ' ' VAL . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.92 0.391 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.629 HG21 HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.629 HE22 HG21 ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 53.7 m . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.9 0.381 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 3' ' ' ILE . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.9 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 44' ' ' ILE . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' N ' HD23 ' A' ' 69' ' ' LEU . 74.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.5 t . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.6 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.565 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' N ' HD23 ' A' ' 69' ' ' LEU . 20.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.412 ' C ' HD22 ' A' ' 67' ' ' LEU . 96.4 m . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 69' ' ' LEU . 14.8 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 3' ' ' ILE . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 3' ' ' ILE . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 15' ' ' LEU . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 14' ' ' THR . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.4 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.45 68.0 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m -99.88 120.07 39.2 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.891 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD23 ' A' ' 69' ' ' LEU . 49.9 t -106.74 143.11 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 71' ' ' LEU . 6.6 mt -84.17 -175.53 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -58.65 -50.28 74.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.218 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.0 mt -69.79 132.49 46.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -61.09 -41.15 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.95 -169.27 42.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.743 0 CA-C-O 117.971 -1.461 . . . . 0.0 110.99 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HZ2' ' HG ' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HG ' ' HZ2' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 58.04 68.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -99.74 125.01 45.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.854 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.6 t -106.5 140.42 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -110.74 172.93 6.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -64.32 -52.0 60.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.5 mp -66.63 125.34 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 54.84 28.48 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.03 -55.25 30.71 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.961 -1.466 . . . . 0.0 110.867 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' ILE . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 15' ' ' LEU . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 14' ' ' THR . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 72' ' ' ARG . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 58.88 69.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m -99.66 123.29 43.78 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.412 ' N ' HD23 ' A' ' 69' ' ' LEU . 95.3 t -105.75 142.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -70.24 179.9 2.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.052 0.453 . . . . 0.0 110.476 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 40' ' ' GLN . 46.7 ttp180 -48.52 -49.38 36.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.17 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -83.33 146.55 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.351 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -72.22 136.18 46.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.506 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.16 -69.69 1.25 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.798 -179.894 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HD12 ' A' ' 15' ' ' LEU . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 14' ' ' THR . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 1.1 p-10 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 58.05 68.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' HD22 ' A' ' 67' ' ' LEU . 89.9 m -100.03 123.18 43.98 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -127.03 153.33 36.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -116.84 171.94 7.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.067 0.46 . . . . 0.0 110.464 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -77.24 -45.63 25.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.9 mp -70.22 162.22 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -168.47 -68.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.524 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.75 -46.45 0.26 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 CA-C-O 117.989 -1.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 56.72 63.17 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -131.05 136.37 48.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 69' ' ' LEU . 39.1 t -121.62 149.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -121.18 172.17 8.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.029 0.443 . . . . 0.0 110.42 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -66.48 -38.78 88.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.38 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.98 72.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.062 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -62.33 -17.91 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.3 66.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.907 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' ILE . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.439 ' O ' HD12 ' A' ' 15' ' ' LEU . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 14' ' ' THR . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG21 HE22 ' A' ' 41' ' ' GLN . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HG21 ' A' ' 30' ' ' ILE . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 41' ' ' GLN . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 58.2 68.44 0.83 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -103.4 121.9 43.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.3 t -116.33 145.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -104.07 175.18 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.454 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -70.38 -42.77 71.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.26 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.52 69.92 5.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.273 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 -55.61 139.42 44.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 -30.26 5.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.864 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 43.9 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' O1P' ' A' ' 65' ' ' SEP . 43.0 mt-10 58.48 69.38 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.424 ' O1P' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m -104.5 118.98 37.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.4 t -114.57 144.88 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.66 170.98 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.525 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -58.78 -47.0 86.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.168 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 tp 50.9 99.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.281 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -70.14 133.7 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.21 -66.9 2.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.98 -1.456 . . . . 0.0 110.849 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 3' ' ' ILE . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 58.38 69.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m -101.27 122.74 44.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.676 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.591 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.21 142.22 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.0 mm? -84.36 177.61 8.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -59.99 -50.86 72.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.959 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 tp -90.19 122.52 33.21 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.34 164.22 23.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.62 34.75 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.009 -1.439 . . . . 0.0 110.866 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 58.41 68.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m -102.1 122.57 44.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.0 t -110.88 146.22 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 71' ' ' LEU . 7.4 mt -85.11 -176.69 6.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -64.27 -44.15 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 73' ' ' LEU . 7.1 mp -78.09 108.1 11.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.286 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -65.73 -75.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 167.86 28.38 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 CA-C-O 117.923 -1.487 . . . . 0.0 110.818 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.8 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' OE1' ' A' ' 41' ' ' GLN . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.46 67.68 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -97.38 120.76 38.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.711 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t -110.95 142.4 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.89 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -122.53 172.92 8.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 110.869 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -63.96 -53.54 48.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.414 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 73' ' ' LEU . 8.6 mp -70.23 102.94 2.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -66.41 -38.18 86.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.09 -132.89 24.02 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.756 0 CA-C-O 117.958 -1.468 . . . . 0.0 110.94 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 14.1 m120 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' C ' HE22 ' A' ' 62' ' ' GLN . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.51 HE22 ' C ' ' A' ' 60' ' ' ASN . 24.6 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 57.19 68.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -99.76 123.89 44.48 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.617 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.3 144.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.45 171.93 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 0.0 110.414 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -67.29 -48.56 67.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.02 90.4 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.436 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.77 -47.18 86.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.661 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -127.29 1.29 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.998 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD12 ' A' ' 44' ' ' ILE . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' OD1' ' NE2' ' A' ' 62' ' ' GLN . 25.5 t-20 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' CD ' ' N ' ' A' ' 62' ' ' GLN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 57.25 68.99 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -98.95 119.46 37.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.407 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.2 t -103.67 140.09 22.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -116.55 171.94 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.7 -49.27 63.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.381 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 73' ' ' LEU . 8.4 mp -66.42 137.84 57.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.229 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 51.87 18.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.36 -21.94 72.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.979 -1.456 . . . . 0.0 110.877 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.3 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' ARG . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 58.07 69.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m -102.17 122.82 44.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.9 t -114.37 145.53 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.39 -175.7 5.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' GLN . 50.8 ttt85 -54.75 -46.3 74.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.304 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.78 125.6 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.235 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -62.29 -36.7 82.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.739 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.29 -107.43 0.67 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.815 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.6 t-20 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.35 68.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -101.66 120.58 40.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.752 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.4 t -108.37 146.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 71' ' ' LEU . 6.7 mt -72.01 -175.47 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.525 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -64.08 -21.62 66.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -71.71 121.89 19.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -79.0 -28.59 43.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.04 114.59 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.8 0 CA-C-O 118.047 -1.418 . . . . 0.0 110.92 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 3' ' ' ILE . 33.1 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 57.23 68.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -96.96 122.07 39.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.85 139.42 23.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -86.35 173.6 9.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.173 0.511 . . . . 0.0 110.328 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -55.97 -13.97 2.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tp 59.26 62.93 1.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.213 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -62.76 -40.28 96.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.799 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.21 -149.13 17.05 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.899 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 57.03 67.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -101.29 121.02 41.13 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.713 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.24 142.67 19.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -119.43 166.27 13.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.089 0.471 . . . . 0.0 110.521 -179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -85.82 -56.27 3.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -169.16 106.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -61.48 -49.21 77.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.5 -100.15 0.14 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.976 -1.458 . . . . 0.0 110.896 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 58.62 69.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -100.71 122.0 42.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.8 t -108.15 141.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -107.25 166.26 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 110.475 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -80.43 -38.55 29.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.243 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -84.4 60.33 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.302 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -69.07 -27.06 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.03 141.08 27.61 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.023 -1.432 . . . . 0.0 110.89 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 3' ' ' ILE . 82.3 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 58.13 69.56 0.72 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.449 ' C ' HD22 ' A' ' 67' ' ' LEU . 49.4 m -103.05 127.31 50.35 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -107.9 141.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -101.37 175.94 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.48 . . . . 0.0 110.349 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -67.29 -41.01 86.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -83.96 77.34 9.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.256 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -56.6 -33.05 65.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.887 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.9 -141.29 48.16 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.758 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.892 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.44 69.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m -98.53 121.77 40.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.499 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.0 m -119.11 150.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 71' ' ' LEU . 7.7 mt -66.75 -175.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.866 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 73' ' ' LEU . 16.9 ptm180 -56.5 -24.62 47.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.265 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 72' ' ' ARG . 5.2 mp 47.12 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 46.47 83.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.14 -137.7 2.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 118.046 -1.419 . . . . 0.0 110.94 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.517 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 14' ' ' THR . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 47.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 58.71 69.73 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -104.04 125.03 50.08 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.9 t -110.21 143.88 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 71' ' ' LEU . 7.9 mt -78.11 -175.65 4.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.43 -40.92 72.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.76 131.53 39.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.357 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -64.13 -42.06 96.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.65 164.41 34.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.94 -1.478 . . . . 0.0 110.924 179.899 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 23' ' ' ILE . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 57.1 69.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m -99.16 120.21 39.13 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.432 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.07 152.39 36.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.87 -176.44 6.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.692 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -77.01 -56.41 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.3 -15.38 53.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.999 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 54.31 87.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.12 -67.68 0.08 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.026 -0.829 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.006 -1.441 . . . . 0.0 110.954 179.989 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 14' ' ' THR . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 17' ' ' VAL . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' OD1' ' NH1' ' A' ' 72' ' ' ARG . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 58.93 68.42 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -100.3 122.74 43.57 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.68 150.05 27.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.62 -177.23 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.756 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' NH1' ' OD1' ' A' ' 39' ' ' ASP . 36.8 ttm180 -70.83 -38.79 73.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.41 130.95 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -71.37 120.59 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.479 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.03 80.88 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.077 -1.401 . . . . 0.0 110.872 179.926 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.629 HG21 HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.629 HE22 HG21 ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.59 69.1 0.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 53.7 m -99.8 124.56 45.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.713 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.89 138.88 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 71' ' ' LEU . 6.2 mt -78.6 -175.68 4.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.591 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -61.76 -38.14 86.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.2 mp -61.99 143.56 56.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.049 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.52 129.12 38.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 53.98 -102.98 0.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.9 -179.832 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 3' ' ' ILE . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.9 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 44' ' ' ILE . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 58.03 68.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m -101.93 122.08 43.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' N ' HD23 ' A' ' 69' ' ' LEU . 74.5 t -106.62 140.11 25.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.23 171.02 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 110.391 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.67 -49.69 76.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 73' ' ' LEU . 1.3 tt 65.65 107.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.101 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' N ' HD23 ' A' ' 73' ' ' LEU . 81.1 mtp180 -70.18 131.93 45.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.793 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.68 73.85 0.61 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.933 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 57.41 66.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m -101.97 126.11 48.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t -110.32 143.56 20.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.15 170.59 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.207 0.527 . . . . 0.0 110.467 -179.546 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -86.51 -50.12 7.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.322 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -160.12 178.3 9.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -157.32 161.84 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.576 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.41 -77.02 0.15 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.966 -1.463 . . . . 0.0 110.841 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 58.25 69.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m -98.98 122.95 42.91 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.5 t -110.26 143.28 20.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -92.48 174.45 7.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.57 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -54.9 -52.55 62.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.35 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' O ' HD21 ' A' ' 71' ' ' LEU . 57.2 tp -71.74 136.03 47.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.257 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -148.82 156.92 43.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.62 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.49 -178.55 53.64 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.924 -1.486 . . . . 0.0 110.812 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.6 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.565 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 57.3 68.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -103.09 120.13 40.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' N ' HD23 ' A' ' 69' ' ' LEU . 20.5 t -111.42 144.87 18.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.87 162.12 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 110.417 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -85.89 -62.08 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.069 179.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.3 mt -107.74 145.46 33.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.224 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -55.94 -36.62 67.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.747 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.74 132.97 1.52 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 117.952 -1.471 . . . . 0.0 111.01 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 57.88 68.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.412 ' C ' HD22 ' A' ' 67' ' ' LEU . 96.4 m -97.37 121.98 39.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.645 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 69' ' ' LEU . 14.8 p -126.29 151.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 71' ' ' LEU . 8.0 mt -78.8 -178.07 5.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -77.73 -41.33 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.227 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 tp 57.11 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.01 -40.44 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.45 18.86 72.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.013 -1.437 . . . . 0.0 110.954 -179.893 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 58.43 69.39 0.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.19 121.82 42.53 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.61 142.11 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -119.53 170.4 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.117 0.484 . . . . 0.0 110.408 -179.723 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -62.06 -16.27 50.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.355 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER 70.77 37.86 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.6 91.36 7.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.424 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.47 161.21 25.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 3' ' ' ILE . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.56 65.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 121.88 38.39 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.679 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.04 148.31 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -72.4 -175.61 1.63 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -47.58 -34.0 7.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.8 mp -62.7 146.42 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.92 151.56 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.755 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.7 -33.76 35.04 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.022 -1.432 . . . . 0.0 110.922 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 3' ' ' ILE . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 15' ' ' LEU . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 14' ' ' THR . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.3 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD23 ' A' ' 69' ' ' LEU . 49.9 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HZ2' ' HG ' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HG ' ' HZ2' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.873 0.368 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.6 t . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' ILE . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 15' ' ' LEU . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 14' ' ' THR . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.412 ' N ' HD23 ' A' ' 69' ' ' LEU . 95.3 t . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HD12 ' A' ' 15' ' ' LEU . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 14' ' ' THR . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.7 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' HD22 ' A' ' 67' ' ' LEU . 89.9 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.1 p . . . . . 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 69' ' ' LEU . 39.1 t . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' ILE . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.439 ' O ' HD12 ' A' ' 15' ' ' LEU . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 14' ' ' THR . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG21 HE22 ' A' ' 41' ' ' GLN . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HG21 ' A' ' 30' ' ' ILE . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 41' ' ' GLN . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.3 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.486 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.8 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.4 t . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 3' ' ' ILE . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.591 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH2' HE22 ' A' ' 49' ' ' GLN . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.518 HE22 ' NH2' ' A' ' 42' ' ' ARG . 35.0 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.937 0.398 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.0 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.5 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' OE1' ' A' ' 41' ' ' GLN . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.891 0.377 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 70.9 m-20 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 14.8 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 3.1 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.934 0.397 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD12 ' A' ' 44' ' ' ILE . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.662 ' ND2' HE22 ' A' ' 62' ' ' GLN . 27.1 t30 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.662 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.407 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.2 t . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.0 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.431 HH21 ' NE2' ' A' ' 49' ' ' GLN . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' NE2' HH21 ' A' ' 42' ' ' ARG . 37.0 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.9 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' NZ ' ' A' ' 29' ' ' LYS . 31.1 t30 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.4 t . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 3' ' ' ILE . 87.6 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.902 0.382 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.8 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 3' ' ' ILE . 24.1 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' C ' HD22 ' A' ' 60' ' ' ASN . 0.1 OUTLIER -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.449 ' C ' HD22 ' A' ' 67' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.499 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.0 m . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.517 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 14' ' ' THR . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.9 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 23' ' ' ILE . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 14' ' ' THR . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 17' ' ' VAL . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.92 0.391 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.629 HG21 HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.629 HE22 HG21 ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 53.7 m . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.9 0.381 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 3' ' ' ILE . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.8 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 44' ' ' ILE . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' N ' HD23 ' A' ' 69' ' ' LEU . 74.5 t . . . . . 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.974 0.416 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.5 t . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.565 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.0 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' HE21 ' A' ' 31' ' ' GLN . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.565 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' N ' HD23 ' A' ' 69' ' ' LEU . 20.5 t . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.412 ' C ' HD22 ' A' ' 67' ' ' LEU . 96.4 m . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 69' ' ' LEU . 14.8 p . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 3' ' ' ILE . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 3' ' ' ILE . 67.6 mt-30 -117.39 158.52 24.3 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.018 0.437 . . . . 0.0 110.358 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.54 172.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.113 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -110.4 140.23 44.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.577 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.93 128.92 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -112.96 132.03 55.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.551 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -107.83 -177.59 3.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.006 0.431 . . . . 0.0 110.428 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.5 mm? -72.07 -23.85 61.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -82.15 8.79 9.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.0 23.46 76.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -87.97 132.09 34.37 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.2 m -116.11 123.52 48.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.62 143.47 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.295 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 15' ' ' LEU . 6.5 m -98.94 138.25 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.472 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 14' ' ' THR . 4.3 mp -124.92 149.08 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.966 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 6.2 pt-20 -107.36 122.29 46.28 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.53 165.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.753 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.56 150.39 36.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.65 -14.59 45.47 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.99 1.794 . . . . 0.0 111.486 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -103.01 7.87 39.01 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.286 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -67.79 146.18 53.97 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -88.34 150.33 23.27 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.15 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -52.91 -21.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.758 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.9 -57.16 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.026 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 93.6 m-20 -53.57 -42.1 67.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.62 -42.25 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.447 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.92 -37.21 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.58 -39.35 83.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.835 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 90.8 mttt -64.69 -39.21 93.27 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.25 -46.06 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.228 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.3 tt0 -60.54 -46.29 90.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 110.462 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -56.34 -38.8 71.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.719 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.83 -38.95 15.26 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.82 -11.0 21.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.83 10.35 38.13 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.525 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.6 mt -89.2 116.4 66.23 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.239 0.52 . . . . 0.0 110.236 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.3 145.17 2.52 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.869 1.713 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.05 -22.07 26.69 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.416 2.077 . . . . 0.0 112.146 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.53 -11.03 59.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -102.85 -9.37 19.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.895 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -116.3 147.59 41.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.442 0.639 . . . . 0.0 112.07 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -130.13 135.92 48.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.309 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -109.3 127.09 54.03 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.645 0.26 . . . . 0.0 110.633 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.52 143.94 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.406 0.622 . . . . 0.0 111.386 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -148.64 143.3 26.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.758 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.47 39.18 20.26 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.279 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 10.17 29.59 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.391 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.77 140.11 50.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.103 0.952 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -83.07 134.44 35.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.982 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.11 130.11 36.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 111.084 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -88.49 143.0 27.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.6 0.714 . . . . 0.0 111.705 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.0 138.6 57.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.639 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.77 -9.71 68.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -96.43 155.92 16.56 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.231 0.516 . . . . 0.0 110.59 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -99.27 160.92 13.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.51 -41.44 85.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.936 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 m -46.61 -35.07 5.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.32 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -55.86 -44.4 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 91.7 m-85 -102.79 102.05 12.17 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.485 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -46.96 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.76 98.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -83.12 174.39 10.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.298 0.57 . . . . 0.0 112.477 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.9 146.86 45.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.906 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.45 68.0 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.877 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.0 m -99.88 120.07 39.2 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.891 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.11 144.5 28.18 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.598 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -96.76 121.86 39.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.19 107.9 18.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD23 ' A' ' 69' ' ' LEU . 49.9 t -106.74 143.11 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.046 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 71' ' ' LEU . 6.6 mt -84.17 -175.53 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -58.65 -50.28 74.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.218 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.0 mt -69.79 132.49 46.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -61.09 -41.15 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.95 -169.27 42.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.743 0 CA-C-O 117.971 -1.461 . . . . 0.0 110.99 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -116.47 153.54 31.93 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.532 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.05 170.61 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -112.24 140.33 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.521 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -116.32 129.67 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -112.2 132.16 55.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.716 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.52 -179.31 3.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 110.269 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.8 mp -73.95 -14.32 61.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.519 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -90.51 8.86 31.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.22 22.41 77.43 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -89.31 132.51 34.89 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -118.08 124.68 48.66 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 pt -134.86 143.04 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.256 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.3 m -94.3 134.66 36.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.504 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -121.26 143.91 48.9 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.028 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.89 120.9 42.55 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.28 164.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 111.731 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -97.6 150.43 36.78 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.02 -12.84 36.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.889 1.726 . . . . 0.0 111.457 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -105.75 10.5 32.7 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.439 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 144.2 53.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -88.61 155.11 19.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.098 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -54.31 -22.18 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.746 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.85 -53.8 7.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.013 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -57.13 -42.58 81.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.579 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.8 -39.87 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.508 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HZ2' ' HG ' ' A' ' 43' ' ' LEU . 25.2 mttp -64.12 -37.18 86.51 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.26 80.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.048 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -64.68 -38.78 92.16 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.94 -47.27 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.283 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 4.4 tt0 -58.89 -47.0 86.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.67 -35.4 74.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.838 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -80.37 -39.39 28.56 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -112.42 -1.42 15.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.76 20.21 56.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.449 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.42 111.77 55.03 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.32 0.56 . . . . 0.0 110.411 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.1 146.46 2.66 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.912 1.741 . . . . 0.0 112.177 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 -16.44 31.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.568 2.179 . . . . 0.0 112.34 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.92 -15.22 59.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -104.37 -8.16 19.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -115.18 144.67 43.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.332 0.587 . . . . 0.0 111.946 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 mmm-85 -131.63 138.88 48.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.54 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HG ' ' HZ2' ' A' ' 27' ' ' LYS . 42.5 mt -116.42 131.66 56.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.695 0.283 . . . . 0.0 110.866 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.5 145.26 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.412 0.625 . . . . 0.0 111.363 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.11 145.87 26.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.758 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 36.83 13.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.41 9.74 25.64 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.361 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.38 141.46 48.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 118.018 0.909 . . . . 0.0 111.782 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -80.51 133.67 35.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.157 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 mt -76.0 126.31 30.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 0.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -87.84 141.38 28.64 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.742 0.782 . . . . 0.0 111.592 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -64.68 132.75 50.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.601 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.93 -9.98 55.38 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -95.96 154.25 17.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.361 0.58 . . . . 0.0 110.499 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.49 160.11 14.53 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -56.4 -40.6 74.92 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.918 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.2 m -45.66 -38.36 6.67 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.451 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.34 -45.22 80.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.7 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -97.24 97.95 9.59 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.567 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.07 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.7 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.0 mt -98.85 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -85.51 175.68 8.67 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.276 0.56 . . . . 0.0 112.176 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.31 146.54 43.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.994 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 58.04 68.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -99.74 125.01 45.57 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.854 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.74 149.34 24.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.732 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -95.19 120.87 36.16 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.491 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.1 tt -109.97 106.31 15.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.6 t -106.5 140.42 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.571 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -110.74 172.93 6.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -64.32 -52.0 60.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.5 mp -66.63 125.34 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 54.84 28.48 10.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.03 -55.25 30.71 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.961 -1.466 . . . . 0.0 110.867 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.12 155.57 26.84 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.943 0.401 . . . . 0.0 110.674 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.26 171.03 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.053 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.53 140.57 47.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.662 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 t -115.36 127.52 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -109.4 131.38 55.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.729 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 p -105.94 -178.61 3.7 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.148 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.74 -29.89 66.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -77.95 10.61 2.73 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.92 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.88 24.09 75.73 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -87.93 132.14 34.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -116.4 124.22 49.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' ILE . 10.3 tp -132.4 142.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.227 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 15' ' ' LEU . 14.7 m -98.13 136.41 38.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.654 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 14' ' ' THR . 4.4 mp -126.18 150.48 48.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.918 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -107.82 124.25 49.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 163.56 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 6.2 mm-40 -102.79 137.76 19.4 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.924 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.16 -21.89 4.77 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.785 1.657 . . . . 0.0 111.847 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.8 p -95.21 7.37 46.37 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.715 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 70.9 m-20 -69.4 143.52 53.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.5 p -89.0 152.36 21.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.79 -22.56 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.989 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.93 -55.87 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.09 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.35 -40.72 71.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.4 -40.43 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.377 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -63.14 -36.33 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -38.93 86.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.42 -40.31 93.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.65 -46.9 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.318 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.4 tt0 -61.08 -46.15 91.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -56.92 -39.01 73.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.929 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -87.96 -38.58 15.43 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -101.19 -9.81 20.96 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.57 10.91 46.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.491 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 64.7 mt -87.29 113.6 54.69 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 117.264 0.532 . . . . 0.0 110.408 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.72 150.45 2.51 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.864 1.71 . . . . 0.0 112.203 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.92 -20.32 22.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.456 2.104 . . . . 0.0 112.29 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -85.04 -13.12 51.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.978 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 72' ' ' ARG . 44.0 mm-40 -96.31 -8.77 31.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.098 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 22.3 pt20 -127.95 156.53 42.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.47 0.652 . . . . 0.0 111.927 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.612 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 33.5 mmm-85 -132.13 139.33 48.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.52 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -111.44 129.03 56.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.651 0.263 . . . . 0.0 110.697 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -129.98 146.33 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.309 0.576 . . . . 0.0 111.307 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.58 145.86 25.43 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.712 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.28 36.03 11.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 109.188 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.69 8.37 33.03 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.433 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.19 140.65 49.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.016 0.908 . . . . 0.0 111.799 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 39.3 tt0 -81.47 133.55 35.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.961 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.56 128.12 34.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.986 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -88.09 140.91 29.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.717 0.77 . . . . 0.0 111.556 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -64.24 135.24 56.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.636 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -93.72 154.28 17.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.375 0.587 . . . . 0.0 110.535 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.0 p -98.13 158.96 15.24 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.4 -40.51 82.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.844 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.8 p -47.95 -36.07 11.86 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.367 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.13 -42.06 65.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' O ' ' N ' ' A' ' 61' ' ' ILE . 72.9 m-85 -105.57 104.04 13.67 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.656 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -48.54 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.669 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.1 mt -98.16 105.88 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -87.53 172.82 9.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.374 0.607 . . . . 0.0 112.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -58.81 147.23 34.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 58.88 69.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.247 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.0 m -99.66 123.29 43.78 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.49 146.83 24.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.675 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -96.25 121.43 38.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.234 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -110.75 106.77 16.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.412 ' N ' HD23 ' A' ' 69' ' ' LEU . 95.3 t -105.75 142.92 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.826 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -70.24 179.9 2.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.052 0.453 . . . . 0.0 110.476 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 40' ' ' GLN . 46.7 ttp180 -48.52 -49.38 36.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.17 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -83.33 146.55 28.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.351 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -72.22 136.18 46.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.506 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.16 -69.69 1.25 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.798 -179.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -114.73 154.73 27.96 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -151.07 168.56 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.13 143.59 39.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.418 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -117.86 130.22 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -109.79 132.03 54.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.588 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -107.51 -179.86 4.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 110.372 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.94 -18.62 61.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -85.95 8.64 19.64 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.858 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.87 23.68 75.79 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.56 135.95 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -119.96 127.23 52.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 109.835 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -135.45 143.72 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.351 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 ' O ' HD12 ' A' ' 15' ' ' LEU . 12.2 m -96.17 139.56 32.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 14' ' ' THR . 4.2 mp -124.17 148.01 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.867 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.62 120.47 41.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.55 164.58 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.078 0.466 . . . . 0.0 111.667 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.31 149.96 36.26 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.82 -11.87 28.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.993 1.796 . . . . 0.0 111.577 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 t -108.97 10.12 26.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.379 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -66.55 147.49 53.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.779 0.323 . . . . 0.0 110.2 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -90.49 152.07 21.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.931 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -53.69 -19.76 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.851 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -77.46 -58.08 3.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.138 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -54.54 -40.81 69.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.607 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.52 -42.82 94.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.562 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -62.28 -36.61 82.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.29 86.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.093 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -62.27 -39.49 93.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 109.593 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -67.32 -46.02 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' GLY . 7.7 tt0 -59.52 -46.8 87.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -55.51 -40.19 71.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.656 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.93 -38.67 19.08 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -100.44 -9.34 22.26 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.75 15.03 53.75 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.312 -0.47 . . . . 0.0 112.508 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.12 113.69 61.34 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.223 0.511 . . . . 0.0 110.259 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.93 147.64 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.902 1.734 . . . . 0.0 112.094 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -15.56 31.53 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.487 2.125 . . . . 0.0 112.36 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.78 -15.52 59.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.772 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -104.42 -8.56 19.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -112.99 143.34 44.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.382 0.611 . . . . 0.0 112.127 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -131.75 139.63 49.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.401 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.73 130.39 56.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.64 0.257 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.21 144.81 36.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.291 0.567 . . . . 0.0 111.285 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -151.29 144.51 24.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.686 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.78 36.95 19.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.51 9.81 19.92 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.321 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -116.32 140.78 48.96 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.145 0.973 . . . . 0.0 111.693 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -79.67 133.24 36.37 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.1 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.48 126.21 30.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 111.056 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.85 138.25 35.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.647 0.737 . . . . 0.0 111.679 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -65.89 136.75 56.55 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.537 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.15 65.48 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -93.91 157.36 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.18 0.49 . . . . 0.0 110.61 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.5 p -101.14 161.94 13.24 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.32 -41.26 93.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.777 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 m -46.03 -37.77 7.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.358 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -54.99 -43.6 73.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 61' ' ' ILE . 77.7 m-85 -103.97 102.38 12.15 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.577 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -49.27 64.98 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.3 mt -95.03 103.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -83.98 168.46 15.96 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.467 0.651 . . . . 0.0 112.369 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.2 148.31 27.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.967 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 58.05 68.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.177 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' HD22 ' A' ' 67' ' ' LEU . 89.9 m -100.03 123.18 43.98 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.962 0.41 . . . . 0.0 110.592 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -101.18 149.88 23.53 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.01 121.46 38.92 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.096 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.8 tt -109.63 112.02 23.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.1 p -127.03 153.33 36.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.654 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -116.84 171.94 7.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.067 0.46 . . . . 0.0 110.464 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -77.24 -45.63 25.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.231 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.9 mp -70.22 162.22 28.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -168.47 -68.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.524 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.75 -46.45 0.26 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 CA-C-O 117.989 -1.451 . . . . 0.0 111.036 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.0 pt20 -118.04 156.96 27.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.74 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.5 pt -156.58 171.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.174 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.11 143.34 42.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.639 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.77 132.33 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -113.26 133.78 54.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.92 -178.07 3.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -72.38 -21.32 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.786 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -84.74 9.11 14.9 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.979 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.9 23.42 75.87 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.98 133.23 34.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -116.08 124.1 49.56 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.29 142.4 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -97.26 137.25 36.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.86 146.32 48.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.066 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.53 123.26 48.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.01 169.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.196 0.522 . . . . 0.0 111.641 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -102.98 151.84 38.45 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.06 -15.59 49.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.906 1.737 . . . . 0.0 111.415 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 t -101.84 6.82 41.72 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.339 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.05 146.5 54.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.218 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -90.87 151.81 20.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -51.77 -20.67 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.785 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.94 -54.3 6.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.935 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -56.43 -42.12 77.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.12 -42.3 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.589 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.17 -37.05 83.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.09 82.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.225 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -65.32 -41.32 94.1 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.419 0.628 . . . . 0.0 109.609 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.55 -45.74 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.237 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 53.1 tt0 -60.7 -45.87 92.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.531 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.66 -38.17 71.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.845 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -89.84 -37.01 14.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -100.69 -12.19 19.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.43 16.4 58.35 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.652 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.1 mt -93.58 116.37 66.37 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.284 0.542 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -44.62 144.81 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.904 1.736 . . . . 0.0 112.33 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.93 -26.29 26.93 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.537 2.158 . . . . 0.0 112.332 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.67 -13.24 60.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -103.81 -5.88 21.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.881 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.1 142.2 43.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.219 0.533 . . . . 0.0 112.165 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -127.5 132.86 49.91 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.21 120.39 41.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.972 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.42 132.27 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.017 0.437 . . . . 0.0 110.693 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -148.22 141.81 25.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.94 33.26 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.49 10.3 48.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.409 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -118.68 140.4 49.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.087 0.944 . . . . 0.0 111.781 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -81.82 133.52 35.34 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.875 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.76 126.11 29.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.026 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -85.52 140.83 30.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.727 0.775 . . . . 0.0 111.687 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.05 137.32 57.93 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.64 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.11 -8.38 67.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -96.03 157.72 15.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 117.516 0.658 . . . . 0.0 110.651 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -101.8 160.34 14.56 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.89 -39.87 72.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.857 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.1 p -45.96 -33.3 3.23 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.372 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.58 -45.86 84.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' O ' ' N ' ' A' ' 61' ' ' ILE . 80.8 m-85 -101.43 99.79 10.17 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.676 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -47.12 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 59' ' ' TYR . 95.2 mt -98.28 100.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -84.93 177.13 8.07 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.349 0.595 . . . . 0.0 112.251 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -65.14 149.79 49.29 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.055 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 56.72 63.17 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.865 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -131.05 136.37 48.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.856 0.36 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.12 171.54 8.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.418 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -104.57 125.86 51.11 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -109.09 113.48 26.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 69' ' ' LEU . 39.1 t -121.62 149.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -121.18 172.17 8.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.029 0.443 . . . . 0.0 110.42 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -66.48 -38.78 88.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.38 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.98 72.63 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.062 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -62.33 -17.91 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.3 66.04 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.907 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' ILE . 46.3 mt-30 -115.51 156.42 25.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.74 171.16 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.104 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.37 139.4 46.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.518 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 t -116.36 127.95 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -110.7 133.02 53.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.878 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -107.28 -179.3 3.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.026 0.441 . . . . 0.0 110.153 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -73.42 -17.65 61.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.553 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -86.68 9.54 18.45 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.33 22.02 74.45 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -91.27 135.05 34.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -118.3 127.2 53.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 109.708 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.06 142.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.439 ' O ' HD12 ' A' ' 15' ' ' LEU . 7.2 m -102.91 140.54 37.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.236 0.541 . . . . 0.0 110.566 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 14' ' ' THR . 1.2 mp -133.84 160.59 37.17 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.67 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -114.5 127.83 56.02 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.94 167.45 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.241 0.543 . . . . 0.0 111.616 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -99.34 151.59 37.48 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.48 -11.8 33.44 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.905 1.736 . . . . 0.0 111.468 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -106.54 8.84 31.55 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.394 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.06 146.79 53.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -90.05 152.67 21.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.051 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -53.94 -20.89 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.889 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.93 -55.35 5.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.975 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 9.9 t-20 -56.66 -42.91 79.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.9 -41.01 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.551 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -64.14 -35.55 81.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.85 -39.12 84.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.034 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.47 -39.15 91.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG21 HE22 ' A' ' 41' ' ' GLN . 4.8 mm -65.87 -48.47 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.584 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -60.0 -44.63 94.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.591 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.91 -40.47 69.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.733 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -90.65 -35.87 14.72 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -99.93 -11.98 20.19 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.69 14.85 58.82 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.829 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.31 111.81 52.19 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 117.297 0.548 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.57 145.7 4.04 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.919 1.746 . . . . 0.0 112.157 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.32 -20.43 32.19 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.52 2.147 . . . . 0.0 112.311 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.84 -17.65 61.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.711 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -106.84 -4.38 19.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.888 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HG21 ' A' ' 30' ' ' ILE . 36.5 tt0 -108.73 138.68 44.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 111.911 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -128.66 134.81 48.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 41' ' ' GLN . 61.4 mt -114.1 129.44 56.62 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.67 0.271 . . . . 0.0 110.767 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -128.56 142.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.546 0.688 . . . . 0.0 111.162 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -147.9 143.13 27.16 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.805 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.2 39.95 24.87 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.172 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.42 10.29 21.87 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.443 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -117.81 140.86 49.1 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.042 0.921 . . . . 0.0 111.706 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -82.91 132.73 35.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.973 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -76.92 132.76 39.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -90.19 141.55 28.59 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.704 0.764 . . . . 0.0 111.749 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.94 133.93 52.84 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.555 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.7 -10.2 57.36 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -95.09 156.54 16.27 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.275 0.537 . . . . 0.0 110.576 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.8 p -100.11 160.28 14.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.879 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.07 -39.85 75.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.927 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.1 m -47.12 -35.96 7.77 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.433 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -57.33 -45.41 84.3 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 90.6 m-85 -99.07 99.53 10.56 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.561 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -46.67 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -98.93 100.84 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -85.17 176.69 8.21 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 112.142 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.46 145.41 48.38 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.043 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 58.2 68.44 0.83 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.993 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -103.4 121.9 43.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.1 tp -101.69 147.34 26.57 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.544 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.12 121.47 40.07 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.8 tt -107.53 109.7 21.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.3 t -116.33 145.77 21.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.844 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -104.07 175.18 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.454 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -70.38 -42.77 71.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.26 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.52 69.92 5.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.273 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 -55.61 139.42 44.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 -30.26 5.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.864 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.3 mt-30 -115.85 154.1 30.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.11 170.03 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.119 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -109.69 141.87 41.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.433 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.27 130.26 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -112.33 132.84 54.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.715 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -106.62 179.66 4.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.118 0.485 . . . . 0.0 110.152 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.51 -16.87 61.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.812 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.81 10.08 24.96 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.39 23.75 77.24 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -88.08 130.83 34.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.7 m -118.17 124.86 49.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.183 0.516 . . . . 0.0 109.645 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.72 144.81 31.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.192 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -95.91 137.06 35.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 147.02 47.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.121 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -108.73 122.78 47.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.02 167.22 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.308 0.575 . . . . 0.0 111.611 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.51 151.64 38.13 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.866 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -10.27 28.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.824 1.682 . . . . 0.0 111.463 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 t -109.73 7.95 24.5 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.443 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -64.51 149.03 49.42 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -91.2 153.21 20.17 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.8 mm -54.33 -21.18 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.74 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -77.49 -53.7 7.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.949 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.486 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -57.21 -42.1 80.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.526 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.16 -41.61 92.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.571 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 31.2 mttp -63.76 -37.98 89.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.2 81.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.222 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.14 -38.93 89.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.511 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.3 mt -66.01 -48.31 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.8 tt0 -60.49 -43.87 96.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.64 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.8 -40.41 75.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.682 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -87.96 -36.76 16.9 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.79 -10.67 22.71 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.29 13.84 45.06 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.561 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mm -94.18 113.95 62.02 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.237 0.518 . . . . 0.0 110.493 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -44.39 143.86 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.893 1.729 . . . . 0.0 112.16 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 -19.28 34.74 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.545 2.164 . . . . 0.0 112.469 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -74.08 -15.1 61.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -105.58 -5.76 19.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.87 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.53 143.26 45.26 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.299 0.571 . . . . 0.0 111.956 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -131.51 137.68 48.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.349 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 39.2 mt -115.05 131.47 56.91 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.676 0.274 . . . . 0.0 110.872 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.88 143.36 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.328 0.585 . . . . 0.0 111.162 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -148.62 141.97 25.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.711 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.28 36.85 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.663 0.744 . . . . 0.0 109.142 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.93 10.72 33.96 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.449 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -116.67 141.18 48.53 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.984 0.892 . . . . 0.0 111.871 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -81.54 132.84 35.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.895 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.59 126.74 31.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -88.42 141.42 28.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.688 0.756 . . . . 0.0 111.646 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -64.97 136.19 56.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.601 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.5 61.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -97.25 156.31 16.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.268 0.534 . . . . 0.0 110.707 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -100.14 160.96 13.92 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.21 -39.1 71.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.851 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t -46.15 -35.16 4.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.79 -45.03 70.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.65 ' O ' ' N ' ' A' ' 61' ' ' ILE . 56.6 m-85 -106.19 101.35 10.83 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.772 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -48.13 66.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -95.67 100.94 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.68 176.26 8.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.354 0.597 . . . . 0.0 112.385 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -60.73 146.14 46.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.977 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' O1P' ' A' ' 65' ' ' SEP . 43.0 mt-10 58.48 69.38 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.007 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.424 ' O1P' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.1 m -104.5 118.98 37.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.017 0.437 . . . . 0.0 110.668 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.04 144.66 27.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.673 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -94.38 121.1 35.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.384 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -110.21 108.67 18.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.4 t -114.57 144.88 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.72 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.66 170.98 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.525 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -58.78 -47.0 86.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.168 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 tp 50.9 99.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.281 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -70.14 133.7 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.21 -66.9 2.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.98 -1.456 . . . . 0.0 110.849 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 3' ' ' ILE . 75.8 mt-30 -115.89 156.72 25.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.927 0.394 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.37 172.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.07 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -114.55 141.51 47.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.25 125.25 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -106.41 130.6 54.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.546 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -105.28 178.97 4.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.117 0.484 . . . . 0.0 110.302 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.46 -15.17 61.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.599 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 p -90.06 10.71 23.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.053 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.2 74.47 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.289 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -90.12 134.81 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -117.08 124.95 50.5 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.5 tt -131.6 142.74 42.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.099 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 m -101.64 136.43 41.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.48 151.52 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.048 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -104.3 121.35 43.15 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.38 163.69 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.242 0.544 . . . . 0.0 111.195 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.73 150.14 36.55 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.0 -11.66 25.82 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.94 1.76 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.5 t -107.8 8.3 28.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -65.04 146.71 54.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.0 p -89.25 148.18 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 0.0 109.991 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -50.85 -21.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.238 0.542 . . . . 0.0 109.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.09 -55.18 5.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.042 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.493 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.0 t-20 -55.88 -41.04 73.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.618 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -65.88 -40.83 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -63.21 -36.85 85.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.57 84.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.166 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 62.9 mttp -64.26 -40.74 96.62 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.519 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.297 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 11.0 tt0 -59.93 -45.5 92.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.456 . . . . 0.0 110.424 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -55.72 -39.73 71.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.635 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -89.56 -37.7 14.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.9 -10.63 26.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.16 13.19 57.36 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.804 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 mm -96.95 133.02 24.79 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 117.377 0.588 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.31 151.22 54.03 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.813 1.675 . . . . 0.0 111.96 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.0 -12.52 34.54 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.766 2.311 . . . . 0.0 112.257 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.19 -23.05 59.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.3 -7.76 19.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.179 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.0 145.82 42.65 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.364 0.602 . . . . 0.0 112.011 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -132.01 138.75 48.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.514 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -112.13 129.55 56.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.775 0.321 . . . . 0.0 110.874 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.07 144.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.379 0.609 . . . . 0.0 111.386 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -149.21 142.04 24.66 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.701 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.15 37.22 17.66 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.271 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 10.04 36.26 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.489 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.38 139.57 49.89 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.075 0.937 . . . . 0.0 111.56 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -80.4 134.81 36.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.12 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -80.34 130.26 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.373 . . . . 0.0 110.732 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.88 140.85 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.82 0.819 . . . . 0.0 111.8 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.25 136.1 57.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.88 -12.22 59.16 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -93.68 157.05 16.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.321 0.56 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -100.98 159.77 14.94 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.6 -40.94 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.788 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -49.42 -35.33 18.86 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.424 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -53.11 -41.08 64.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.671 ' O ' ' N ' ' A' ' 61' ' ' ILE . 88.2 m-85 -107.33 107.1 17.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.666 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.3 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.6 mt -98.97 103.12 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -86.59 171.61 10.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.403 0.62 . . . . 0.0 112.257 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.68 147.36 33.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.909 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 58.38 69.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.94 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.2 m -101.27 122.74 44.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.676 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -96.78 142.67 28.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.685 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -94.02 120.37 34.18 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.591 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.2 tt -106.68 104.11 13.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.21 142.22 18.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.101 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.0 mm? -84.36 177.61 8.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -59.99 -50.86 72.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.959 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 tp -90.19 122.52 33.21 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.34 164.22 23.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.62 34.75 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.009 -1.439 . . . . 0.0 110.866 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 12.9 pt20 -115.66 155.65 27.3 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.338 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.0 pt -155.71 174.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.217 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.4 139.28 49.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.7 t -112.49 119.21 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -100.88 129.1 46.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -98.77 174.19 6.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.79 -30.47 66.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -67.31 -30.03 69.77 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.781 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.19 19.54 7.12 Favored Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -90.47 140.69 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -119.33 126.79 52.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.258 0.551 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.28 143.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.171 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -98.98 134.2 42.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.383 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.13 145.65 47.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.94 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -104.5 121.77 44.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.5 167.93 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -99.04 151.59 37.44 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.81 -13.99 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.896 1.731 . . . . 0.0 111.495 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.5 t -104.37 5.91 34.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -63.44 145.77 54.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.912 0.386 . . . . 0.0 110.217 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -90.06 151.4 21.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.914 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mm -50.72 -22.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.759 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -76.11 -56.64 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.035 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -54.85 -39.49 68.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.26 -39.86 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.656 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -64.26 -39.14 93.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.85 81.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.059 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.03 -40.66 91.21 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.199 0.523 . . . . 0.0 109.704 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -67.61 -47.54 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.9 tt0 -59.79 -46.59 88.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.55 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -57.78 -37.51 73.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.683 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.34 -38.59 16.08 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -101.71 -9.19 21.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.4 12.91 53.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.399 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.0 132.64 30.4 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 117.152 0.476 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.53 148.72 48.43 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.77 1.647 . . . . 0.0 112.016 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.37 -13.75 36.17 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.616 2.211 . . . . 0.0 112.292 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 61.8 t0 -75.16 -21.97 58.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.932 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -102.59 -7.49 21.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.032 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -118.4 148.06 42.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.409 0.623 . . . . 0.0 112.178 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH2' HE22 ' A' ' 49' ' ' GLN . 24.2 mtm180 -130.52 136.83 49.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.372 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.5 mt -109.92 128.71 55.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.688 0.28 . . . . 0.0 110.772 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -130.06 143.32 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.475 0.655 . . . . 0.0 111.316 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -145.64 137.93 25.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.936 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.5 40.32 29.51 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.294 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.11 8.6 24.41 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.315 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -116.19 140.75 48.98 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.214 1.007 . . . . 0.0 111.723 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.518 HE22 ' NH2' ' A' ' 42' ' ' ARG . 35.0 tt0 -83.12 131.49 35.14 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.043 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.3 128.96 36.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.903 0.382 . . . . 0.0 111.061 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.85 142.44 28.06 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.692 0.758 . . . . 0.0 111.771 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -64.61 136.02 56.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.359 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.9 -7.93 63.09 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -95.73 156.03 16.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.375 0.587 . . . . 0.0 110.555 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 p -98.41 160.76 14.07 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.11 -41.45 92.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.854 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -48.91 -34.1 12.1 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.435 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -56.43 -42.36 77.95 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.3 m-85 -102.81 104.58 14.87 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.4 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -46.31 64.23 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -101.68 99.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -87.26 177.23 7.22 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.348 0.594 . . . . 0.0 112.356 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -60.0 144.8 48.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.113 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 58.41 68.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.131 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.9 m -102.1 122.57 44.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.56 143.91 27.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -94.29 119.57 33.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.077 -0.389 . . . . 0.0 110.287 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.7 tt -110.55 106.24 15.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 69' ' ' LEU . 43.0 t -110.88 146.22 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.009 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 71' ' ' LEU . 7.4 mt -85.11 -176.69 6.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -64.27 -44.15 92.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 73' ' ' LEU . 7.1 mp -78.09 108.1 11.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.286 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -65.73 -75.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 167.86 28.38 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 CA-C-O 117.923 -1.487 . . . . 0.0 110.818 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' ILE . 52.5 mt-30 -119.45 161.57 20.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.476 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.1 pt -155.84 171.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -108.33 140.91 40.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -115.98 127.38 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -111.31 131.02 55.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.607 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 p -107.36 -178.57 3.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.054 0.454 . . . . 0.0 110.374 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -70.29 -25.17 63.21 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.682 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.5 p -80.62 9.0 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.04 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.74 75.11 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -90.05 132.79 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -115.85 124.25 50.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.7 143.01 38.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.307 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -95.5 136.95 35.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.382 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.52 145.35 48.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.02 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -102.8 119.06 38.17 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.04 164.76 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 111.411 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -101.41 150.22 37.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.19 -15.3 47.25 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.987 1.791 . . . . 0.0 111.597 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -103.59 8.82 37.61 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.536 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.22 148.61 50.6 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -90.92 153.28 20.3 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -54.74 -21.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.804 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -76.75 -57.55 3.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.055 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -53.86 -42.44 68.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.25 -42.2 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.574 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -61.75 -37.45 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.59 94.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.173 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -61.55 -39.06 89.75 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.271 0.558 . . . . 0.0 109.557 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' CG2' HE22 ' A' ' 41' ' ' GLN . 93.9 mt -68.63 -45.11 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 5.5 tt0 -60.18 -45.55 92.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -56.22 -40.78 74.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.681 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.24 -37.08 15.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -97.96 -11.13 23.42 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.82 9.3 38.79 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.747 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.39 112.92 52.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 117.201 0.5 . . . . 0.0 110.631 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.14 148.95 2.68 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.877 1.718 . . . . 0.0 112.128 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.16 -18.53 30.53 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.53 2.153 . . . . 0.0 112.192 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.35 -15.17 58.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -104.54 -9.13 18.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.076 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 HE22 ' CG2' ' A' ' 30' ' ' ILE . 16.9 tt0 -113.32 143.41 44.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.449 0.642 . . . . 0.0 111.999 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -129.81 135.92 48.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.358 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' OE1' ' A' ' 41' ' ' GLN . 84.3 mt -111.74 128.83 56.21 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.666 0.27 . . . . 0.0 110.809 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.01 143.57 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.247 0.546 . . . . 0.0 111.277 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -149.73 146.98 27.51 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.98 37.01 12.94 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.254 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.67 9.07 24.07 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.351 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -116.96 141.12 48.65 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.058 0.929 . . . . 0.0 111.848 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -79.0 132.02 36.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.986 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.95 123.68 23.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -81.42 137.38 35.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.756 0.789 . . . . 0.0 111.618 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -63.27 142.71 58.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.725 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.28 -9.64 76.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -93.95 155.78 16.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.305 0.553 . . . . 0.0 110.615 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -98.92 160.16 14.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.779 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.844 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.1 p -45.31 -38.8 6.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.391 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -44.03 68.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.6 m-85 -103.45 100.94 10.82 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.491 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -47.98 66.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -97.18 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.58 171.85 12.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.412 0.625 . . . . 0.0 112.378 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -59.33 148.39 32.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.0 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.46 67.68 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.153 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -97.38 120.76 38.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.711 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.1 tp -100.17 145.34 28.13 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.521 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -94.73 119.85 34.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.29 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.9 tt -108.07 109.09 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.5 t -110.95 142.4 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.678 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.89 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -122.53 172.92 8.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 110.869 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -63.96 -53.54 48.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.414 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 73' ' ' LEU . 8.6 mp -70.23 102.94 2.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -66.41 -38.18 86.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.712 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.09 -132.89 24.02 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.756 0 CA-C-O 117.958 -1.468 . . . . 0.0 110.94 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.94 152.57 32.11 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.958 0.409 . . . . 0.0 110.45 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.3 171.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.81 140.68 46.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.679 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.77 129.61 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -112.72 133.43 54.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.748 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -107.41 -177.64 3.41 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 110.322 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -70.42 -27.25 64.12 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.889 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 p -80.12 9.6 5.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.96 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.37 24.27 74.99 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.2 133.24 33.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -118.55 124.27 47.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -135.23 143.0 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.203 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -93.89 135.8 34.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.27 145.26 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.105 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -108.12 123.04 48.1 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.14 166.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.276 0.56 . . . . 0.0 111.622 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -98.71 150.66 36.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.806 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.46 -12.55 35.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.971 1.78 . . . . 0.0 111.415 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.6 t -106.37 8.53 31.72 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.61 146.85 53.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.248 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -90.49 150.43 21.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.6 mm -52.48 -21.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.692 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.9 -54.21 6.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.012 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 70.9 m-20 -56.74 -42.54 79.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.24 -41.05 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.249 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.29 -37.45 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.4 -38.44 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.086 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -65.59 -40.89 93.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 109.603 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.99 -43.0 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.256 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.7 tm0? -61.58 -48.28 81.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.624 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -55.29 -35.63 65.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.56 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -90.61 -38.18 13.31 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.49 -12.44 18.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.72 15.61 41.86 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.656 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.34 117.47 68.42 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 117.214 0.507 . . . . 0.0 110.403 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.67 120.19 3.21 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.685 1.59 . . . . 0.0 112.011 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.34 -35.42 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.609 2.206 . . . . 0.0 112.413 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.57 -12.07 41.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -104.65 -5.0 21.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.002 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.45 142.81 44.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.31 0.576 . . . . 0.0 112.034 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 20.8 mtm180 -127.27 132.29 50.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.01 122.05 46.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.712 0.291 . . . . 0.0 110.74 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.96 131.59 65.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.551 0.691 . . . . 0.0 111.344 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -140.01 132.51 28.62 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.66 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.08 39.43 23.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.92 10.05 43.71 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.406 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -118.17 140.41 49.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.059 0.929 . . . . 0.0 111.833 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 14.8 tt0 -83.3 133.65 34.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.92 130.29 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.008 0.432 . . . . 0.0 110.889 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.84 143.43 26.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 111.743 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.98 142.43 57.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.743 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.6 -10.8 73.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.51 154.69 17.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.307 0.554 . . . . 0.0 110.598 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 p -98.47 158.53 15.53 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.05 -40.41 76.74 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.863 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.2 t -48.91 -33.6 11.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.38 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.96 -44.45 78.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.674 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.5 m-85 -101.56 102.93 13.74 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.018 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -47.81 63.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.54 102.8 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 3.1 mp0 -86.09 175.7 8.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.426 0.632 . . . . 0.0 112.276 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -61.41 147.89 43.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.05 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 57.19 68.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.264 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -99.76 123.89 44.48 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.617 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 tp -102.49 146.44 28.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.707 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -98.35 123.26 42.37 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.03 115.36 29.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.3 144.58 23.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.647 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.45 171.93 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 0.0 110.414 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -67.29 -48.56 67.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -74.02 90.4 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.436 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.77 -47.18 86.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.661 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -127.29 1.29 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.998 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 3' ' ' ILE . 21.1 tt0 -117.46 160.01 21.89 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 110.412 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -155.47 172.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.175 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -111.04 136.66 49.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.8 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -114.07 127.01 71.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -110.86 131.16 55.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.815 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -106.33 -179.54 3.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.078 0.466 . . . . 0.0 110.204 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.75 -24.04 62.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.852 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -83.85 11.93 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.83 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.59 23.41 73.77 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -86.72 132.41 33.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 m -116.09 121.47 42.27 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.225 0.536 . . . . 0.0 109.617 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.95 141.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.116 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 p -97.96 138.42 35.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -125.32 148.75 48.59 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.805 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' OE1' ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -106.8 122.18 45.88 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -144.72 165.92 12.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.34 151.47 37.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.861 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.1 -15.4 49.14 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.916 1.744 . . . . 0.0 111.499 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -103.43 9.39 37.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.401 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -68.72 146.29 53.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.283 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -91.02 153.62 20.01 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mm -54.21 -20.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.855 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.66 -57.34 3.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 42.6 t30 -54.31 -43.56 71.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.95 -42.69 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.49 -37.21 82.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.98 -40.73 90.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.01 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.03 -39.44 94.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.349 0.595 . . . . 0.0 109.52 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.31 -47.85 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.1 tt0 -58.78 -45.71 89.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.99 -41.26 71.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.775 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -88.14 -37.52 16.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -98.34 -12.54 21.38 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.89 12.19 56.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.532 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -94.22 133.39 27.39 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 117.217 0.509 . . . . 0.0 110.249 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.53 150.99 58.42 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.909 1.739 . . . . 0.0 111.984 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 -13.43 35.59 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.502 2.135 . . . . 0.0 112.495 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.81 -19.62 57.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -104.25 -10.63 17.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.903 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -115.47 145.42 42.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.904 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 16.8 mtm180 -130.61 136.11 48.55 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD12 ' A' ' 44' ' ' ILE . 55.5 mt -105.96 124.0 48.87 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.8 mp -122.17 138.38 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.45 0.643 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -144.55 139.26 28.07 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.754 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.83 39.59 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.212 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.6 36.72 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.523 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -119.69 141.87 48.99 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.963 0.881 . . . . 0.0 111.85 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 12.3 tt0 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.935 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -72.77 126.25 29.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.42 142.41 33.0 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.684 0.754 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.33 136.43 55.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.949 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.7 -7.7 68.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -94.52 155.55 16.87 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.226 0.513 . . . . 0.0 110.87 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.6 p -99.38 162.77 12.84 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.39 -40.39 90.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.3 p -47.34 -35.68 8.44 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.44 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -56.9 -45.74 82.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.3 m-85 -99.65 101.25 12.39 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' ND2' HE22 ' A' ' 62' ' ' GLN . 27.1 t30 -47.12 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.76 98.14 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.662 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.6 mp0 -82.34 173.95 11.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 112.249 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -60.11 146.71 42.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.966 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 57.25 68.99 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.134 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -98.95 119.46 37.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.052 0.453 . . . . 0.0 110.42 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.2 tp -96.38 144.12 26.81 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -95.26 119.83 34.44 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.2 tt -108.47 107.74 18.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.407 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.2 t -103.67 140.09 22.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.748 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -116.55 171.94 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 0.0 110.407 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.7 -49.27 63.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.381 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 73' ' ' LEU . 8.4 mp -66.42 137.84 57.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.229 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 51.87 18.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.36 -21.94 72.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.979 -1.456 . . . . 0.0 110.877 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.4 pt20 -117.52 158.48 24.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.025 0.44 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -155.68 170.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.006 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.5 m-85 -110.45 144.1 39.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.836 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.2 t -120.37 130.86 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -111.24 133.45 53.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.854 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -107.44 -179.06 3.81 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 110.141 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.4 mt -72.52 -17.5 61.73 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.747 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.3 p -88.24 9.9 21.43 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.017 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.69 23.16 75.57 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -89.17 133.96 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -119.36 125.49 49.13 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.5 pt -135.39 142.9 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.102 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -95.76 139.16 32.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.607 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 147.16 48.78 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.728 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -107.52 124.22 49.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.6 168.49 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.463 0.649 . . . . 0.0 111.446 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -111.9 146.02 33.92 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.953 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.72 -32.67 56.3 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 121.874 1.716 . . . . 0.0 111.825 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -79.74 4.26 16.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.911 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -72.52 140.84 48.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.187 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -87.03 149.37 24.79 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -52.46 -21.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.723 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.0 -56.03 5.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.034 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.06 -41.64 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.96 -40.33 88.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -63.43 -37.23 86.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.68 79.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.977 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.53 -40.7 93.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.61 -48.91 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.411 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.0 tt0 -59.29 -45.95 89.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.2 -38.84 68.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.683 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -88.15 -37.36 16.23 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.14 -11.71 19.36 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 64.66 12.78 54.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.49 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.69 111.23 50.08 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 117.266 0.533 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.44 146.28 5.21 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.895 1.73 . . . . 0.0 112.155 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.23 -15.21 31.76 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.501 2.134 . . . . 0.0 112.369 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.55 -15.94 59.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' ARG . 76.4 mt-30 -104.45 -8.08 19.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.975 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -117.44 148.01 42.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.428 0.632 . . . . 0.0 112.026 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.431 HH21 ' NE2' ' A' ' 49' ' ' GLN . 32.9 mmt180 -130.82 137.34 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -106.22 119.8 40.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.802 0.334 . . . . 0.0 110.391 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.72 133.95 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.668 0.747 . . . . 0.0 111.399 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -141.26 134.88 30.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.79 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.88 21.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.23 36.54 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.407 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.66 142.66 48.25 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.075 0.937 . . . . 0.0 111.998 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' NE2' HH21 ' A' ' 42' ' ' ARG . 37.0 tt0 -83.22 131.06 35.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.746 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.1 126.33 29.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -81.17 146.87 30.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.908 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -72.75 151.3 42.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.495 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.79 -9.12 69.71 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -100.76 157.68 16.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.207 0.504 . . . . 0.0 110.712 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.1 p -99.36 166.42 11.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.755 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -39.06 86.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -48.86 -35.17 14.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.292 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -57.58 -45.73 84.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.684 ' O ' ' N ' ' A' ' 61' ' ' ILE . 83.4 m-85 -97.73 102.75 14.59 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.795 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -48.11 61.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.66 100.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -83.72 171.99 12.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.472 0.654 . . . . 0.0 112.338 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -58.08 145.74 35.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.931 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 58.07 69.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.288 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.6 m -102.17 122.82 44.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.033 0.444 . . . . 0.0 110.897 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 4.1 mm? -100.95 144.84 29.4 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -98.12 122.81 41.71 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.068 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -108.79 112.42 24.68 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 69' ' ' LEU . 58.9 t -114.37 145.53 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.739 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 mt -83.39 -175.7 5.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.64 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' GLN . 50.8 ttt85 -54.75 -46.3 74.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.304 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.78 125.6 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.235 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -62.29 -36.7 82.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.739 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.29 -107.43 0.67 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.815 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' ILE . 15.6 pt20 -117.91 154.67 31.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.468 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -156.79 172.0 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.102 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -110.07 140.86 43.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.639 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.85 125.86 72.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -108.52 130.66 55.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.624 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -108.04 -178.91 3.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tp -70.65 -26.6 63.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -78.43 8.7 4.73 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.84 23.49 74.18 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.79 135.53 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.7 125.9 51.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.43 143.12 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 m -97.92 136.81 37.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.48 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.14 148.04 48.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -105.77 123.19 47.54 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.21 165.17 11.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.348 0.594 . . . . 0.0 111.572 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.65 152.14 37.76 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.15 -15.89 52.41 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.884 1.722 . . . . 0.0 111.504 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 p -102.61 7.64 39.91 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -67.01 146.06 54.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.182 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.9 p -88.86 148.15 24.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.851 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.92 -21.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.339 -0.544 . . . . 0.0 109.763 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -75.67 -57.4 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.229 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' NZ ' ' A' ' 29' ' ' LYS . 31.1 t30 -53.5 -41.98 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.717 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -65.01 -40.2 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.478 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -62.34 -37.24 84.89 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -60.79 -37.18 81.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.088 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 65.2 mttp -65.02 -39.26 93.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.63 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.11 -46.08 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.438 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.2 tt0 -61.52 -48.69 79.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 0.0 110.701 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.68 -37.67 76.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.84 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -85.19 -40.86 16.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -104.38 -5.32 21.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.2 7.14 50.3 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.599 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.8 129.02 54.07 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 117.277 0.538 . . . . 0.0 110.437 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.84 155.78 39.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.4 -12.2 33.04 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.871 2.381 . . . . 0.0 112.177 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.69 -18.14 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.44 -12.34 21.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.427 0.156 . . . . 0.0 111.16 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -130.77 157.59 42.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.465 0.65 . . . . 0.0 111.899 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -132.66 140.64 48.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.658 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -104.54 126.8 51.97 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.705 0.288 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -128.81 142.75 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.44 0.638 . . . . 0.0 111.23 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -147.62 140.07 24.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.77 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.06 39.59 29.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 8.45 19.92 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.363 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -117.24 141.4 48.34 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.019 0.91 . . . . 0.0 111.853 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.96 133.87 35.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.046 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.01 129.53 36.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.14 147.68 24.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.691 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.09 144.23 50.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.635 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.67 -11.65 69.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -99.4 158.55 15.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 117.2 0.5 . . . . 0.0 110.725 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.1 p -100.8 164.17 11.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.53 -40.05 74.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.808 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 t -46.17 -35.96 5.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.46 -45.75 80.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 58.3 m-85 -102.27 99.59 9.7 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.502 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -47.84 63.75 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -95.22 100.17 10.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.2 173.16 11.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.488 0.661 . . . . 0.0 112.478 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.4 148.07 38.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.079 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.35 68.57 0.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.164 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -101.66 120.58 40.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.752 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.74 139.88 30.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.635 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -93.73 119.58 32.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.9 tt -109.43 106.7 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' N ' HD23 ' A' ' 69' ' ' LEU . 41.4 t -108.37 146.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.806 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 71' ' ' LEU . 6.7 mt -72.01 -175.47 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.525 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -64.08 -21.62 66.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -71.71 121.89 19.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.199 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -79.0 -28.59 43.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.733 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.04 114.59 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.8 0 CA-C-O 118.047 -1.418 . . . . 0.0 110.92 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 3' ' ' ILE . 87.6 mt-30 -117.57 158.9 23.78 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.4 pt -154.63 172.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.075 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.99 140.49 47.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.64 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.26 127.38 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -108.7 130.58 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.695 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -107.28 -179.36 3.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.338 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tp -71.46 -26.23 62.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.99 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -79.72 9.68 4.87 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.834 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.61 74.11 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -88.73 133.95 34.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 m -118.35 123.56 45.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.13 142.5 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.072 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -95.85 137.95 34.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.531 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.15 146.85 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.032 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -102.96 119.92 39.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.12 164.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -102.51 150.6 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.957 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.33 -16.36 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.909 1.74 . . . . 0.0 111.296 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.2 m -101.58 6.9 42.36 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.442 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -66.92 146.56 54.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.2 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -90.47 152.22 21.04 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mm -52.81 -21.08 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.743 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.65 -55.0 5.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.043 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -54.52 -43.68 72.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.521 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.93 -41.13 91.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.436 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.47 -39.06 92.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.36 84.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.227 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -63.4 -39.04 93.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.582 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -68.09 -48.18 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.47 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' N ' ' A' ' 35' ' ' GLY . 45.9 tt0 -59.67 -47.8 84.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.86 -40.27 72.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.666 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -86.28 -38.09 17.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -98.95 -9.32 24.24 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.35 6.71 28.92 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.59 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -88.45 113.92 57.46 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 117.169 0.484 . . . . 0.0 110.427 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.34 147.1 4.24 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.805 1.67 . . . . 0.0 112.07 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.51 -18.59 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.612 2.208 . . . . 0.0 112.361 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.35 -14.7 59.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.883 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -100.45 -7.77 23.91 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -120.75 151.49 39.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 111.961 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -131.67 136.68 47.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.222 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.93 128.86 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 110.758 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mt -127.21 143.55 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.334 0.588 . . . . 0.0 111.383 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -146.73 141.79 27.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.771 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.41 40.05 22.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.177 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.01 7.35 16.41 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.328 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -115.5 139.94 49.6 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 0.0 111.912 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 16.3 tm0? -80.4 133.98 35.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.877 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 30.4 mt -77.0 127.01 31.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.81 140.54 30.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.642 0.734 . . . . 0.0 111.677 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 133.63 52.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.17 60.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -95.34 156.83 16.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.332 0.566 . . . . 0.0 110.738 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.492 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 33.4 p -98.01 159.06 15.18 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.19 -40.2 84.95 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.956 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -47.37 -34.32 6.86 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.379 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 55' ' ' THR . 32.8 m-20 -55.39 -44.49 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' ILE . 89.4 m-85 -103.11 103.95 14.06 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.846 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -47.67 67.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -100.42 98.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.82 172.27 13.03 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.357 0.598 . . . . 0.0 112.288 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -58.64 147.5 32.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.992 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 57.23 68.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.174 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -96.96 122.07 39.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 110.747 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -96.51 146.24 24.98 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.826 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -96.93 119.91 36.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.0 111.26 23.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.85 139.42 23.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.745 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -86.35 173.6 9.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.173 0.511 . . . . 0.0 110.328 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -55.97 -13.97 2.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.285 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tp 59.26 62.93 1.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.213 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -62.76 -40.28 96.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.799 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.21 -149.13 17.05 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 CA-C-O 118.035 -1.425 . . . . 0.0 110.899 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -116.88 155.55 28.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pt -153.82 170.61 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.033 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.57 140.2 47.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.607 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.01 127.35 73.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -108.29 131.47 54.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.617 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -106.52 179.93 4.12 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.092 0.472 . . . . 0.0 110.252 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.98 -22.25 60.72 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.888 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.9 p -83.85 9.71 11.4 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 22.6 77.25 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.32 132.6 34.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -119.3 123.85 45.23 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.54 145.06 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.344 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 m -95.57 136.41 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.56 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.14 144.72 48.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.011 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -104.15 120.98 42.3 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.16 165.3 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 111.545 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -98.88 151.53 37.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.53 -13.49 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.933 1.755 . . . . 0.0 111.408 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 m -105.02 6.46 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.65 148.07 49.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.154 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -91.5 151.01 20.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 mm -50.7 -21.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.634 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.9 -54.83 5.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.05 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -55.04 -41.08 70.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.496 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -68.27 -39.24 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.503 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 26.0 mttp -62.94 -39.53 94.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.81 82.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.98 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.39 -41.9 93.21 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.413 0.625 . . . . 0.0 109.549 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -66.11 -46.98 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.227 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 35' ' ' GLY . 41.4 tt0 -60.3 -45.52 93.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.419 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.69 -37.45 70.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.597 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -89.3 -36.37 15.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -103.28 -10.5 18.66 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.73 15.24 47.19 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.706 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -95.77 110.08 49.53 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 117.301 0.551 . . . . 0.0 110.638 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -45.75 146.09 4.09 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.904 1.736 . . . . 0.0 112.034 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.52 -12.93 32.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.669 2.246 . . . . 0.0 112.383 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.74 -18.83 59.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.92 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -104.32 -7.59 19.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.01 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -116.96 147.31 42.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.418 0.627 . . . . 0.0 112.014 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -130.59 137.97 49.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.402 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 27.7 mt -106.73 120.32 41.67 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.628 0.251 . . . . 0.0 110.512 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.8 mm -115.16 133.09 62.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.465 0.65 . . . . 0.0 111.432 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -143.03 135.02 26.99 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.44 37.85 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.09 10.47 40.52 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.419 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -117.94 140.8 49.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.091 0.946 . . . . 0.0 111.752 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -83.06 133.09 35.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.943 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -74.07 126.39 30.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.947 0.403 . . . . 0.0 111.139 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -86.1 138.49 31.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.586 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.53 134.04 55.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.81 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.09 -11.46 58.71 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' CZ ' ' OD2' ' A' ' 58' ' ' ASP . 17.5 mmm180 -94.58 156.71 16.31 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.349 0.574 . . . . 0.0 110.866 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -100.78 160.74 14.11 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.9 mp -57.96 -40.08 79.7 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.794 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 t -45.51 -38.19 6.07 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.326 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 54' ' ' ARG . 4.3 m-20 -55.23 -44.34 75.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' O ' ' N ' ' A' ' 61' ' ' ILE . 84.8 m-85 -101.37 100.2 10.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.794 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -47.39 65.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.01 99.68 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -86.22 177.28 7.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.406 0.622 . . . . 0.0 112.325 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -61.81 147.07 47.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.905 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 57.03 67.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.614 -1.176 . . . . 0.0 112.181 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -101.29 121.02 41.13 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.713 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 tp -100.11 145.4 28.01 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.392 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -100.81 123.28 44.78 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.261 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.27 111.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.24 142.67 19.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.746 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -119.43 166.27 13.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.089 0.471 . . . . 0.0 110.521 -179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -85.82 -56.27 3.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.428 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -169.16 106.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -61.48 -49.21 77.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.5 -100.15 0.14 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.976 -1.458 . . . . 0.0 110.896 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -116.78 157.33 25.71 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.036 0.446 . . . . 0.0 110.405 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.38 169.84 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.266 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -110.82 141.05 44.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.42 130.23 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -112.33 132.04 55.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.62 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -108.9 -178.02 3.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.118 0.485 . . . . 0.0 110.357 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.24 -30.96 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.873 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -75.18 8.4 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.5 25.2 75.0 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -88.75 132.95 34.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 m -116.95 124.24 48.92 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 tt -135.2 144.07 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.397 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m -96.03 135.27 38.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mp -119.69 142.25 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.113 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -102.09 120.39 40.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.23 165.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.347 0.594 . . . . 0.0 111.617 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.35 147.63 33.57 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.836 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.07 -12.88 32.03 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.017 1.811 . . . . 0.0 111.364 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -104.62 5.45 33.68 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.33 146.3 55.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 p -88.28 148.57 24.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -51.94 -22.23 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.889 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -76.65 -55.52 5.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.0 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -55.74 -39.31 70.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.481 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -66.47 -39.88 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.283 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -62.49 -37.45 86.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.72 84.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.052 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -38.84 92.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 109.629 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.64 -49.07 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.405 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.7 tm0? -58.99 -45.63 90.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.7 -41.66 77.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.607 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -84.69 -37.95 20.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.59 -6.94 24.57 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.93 12.81 37.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.857 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -91.95 114.08 60.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 117.157 0.478 . . . . 0.0 110.522 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.97 144.31 3.82 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.956 1.771 . . . . 0.0 112.114 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.83 -20.06 30.24 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.521 2.147 . . . . 0.0 112.361 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.44 -14.31 60.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -103.5 -6.94 21.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.79 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -116.36 146.38 42.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.343 0.592 . . . . 0.0 112.011 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -131.92 138.83 48.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.411 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.0 mt -113.46 129.69 56.49 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.674 0.273 . . . . 0.0 110.677 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mt -126.11 141.59 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.88 136.43 28.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.906 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.67 43.37 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.342 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.4 10.69 11.69 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.483 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.37 140.85 48.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.024 0.912 . . . . 0.0 111.54 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.82 130.36 35.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.196 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 50' ' ' LEU . 3.6 mm? -71.9 122.31 20.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.942 0.401 . . . . 0.0 110.794 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 88.0 mt-10 -81.88 143.48 31.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.829 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -71.62 150.6 44.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.663 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.27 -11.37 63.36 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 94.0 mtt180 -96.93 156.76 16.21 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.229 0.514 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -99.04 161.37 13.66 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.8 mp -59.12 -40.11 84.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.7 m -49.05 -38.02 22.77 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.382 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -52.93 -42.87 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 95.2 m-85 -103.08 106.23 16.71 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.889 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -47.06 64.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.96 100.0 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -87.19 174.39 8.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.346 0.593 . . . . 0.0 112.324 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -58.86 146.1 38.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.101 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 58.62 69.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.102 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -100.71 122.0 42.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.044 0.449 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.86 145.32 27.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.22 121.98 38.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.0 tt -107.33 107.32 18.18 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 69' ' ' LEU . 54.8 t -108.15 141.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -107.25 166.26 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 110.475 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -80.43 -38.55 29.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.243 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -84.4 60.33 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.302 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -69.07 -27.06 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.03 141.08 27.61 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.023 -1.432 . . . . 0.0 110.89 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 3' ' ' ILE . 24.1 mt-30 -114.02 159.43 19.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.43 . . . . 0.0 110.503 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -156.15 171.89 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -116.14 143.03 46.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.628 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.1 130.35 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -108.63 131.46 54.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.563 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -107.81 -179.03 3.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.042 0.449 . . . . 0.0 110.401 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.87 -33.29 73.55 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.935 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.9 p -74.52 9.58 1.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.99 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.8 24.2 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.68 135.33 33.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 m -118.78 125.1 48.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -133.13 142.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.091 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -99.85 138.55 36.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.722 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.79 151.02 48.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.858 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.02 123.49 48.08 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.47 164.03 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.226 0.536 . . . . 0.0 111.557 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -100.08 151.38 37.5 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.77 -14.82 42.89 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.008 1.806 . . . . 0.0 111.614 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -105.19 8.6 34.09 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.406 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.33 145.02 56.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.307 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.4 p -87.79 147.27 25.24 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -50.13 -23.24 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.856 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.89 -58.59 3.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 46.8 t-20 -52.75 -40.56 63.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.464 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.27 -42.65 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.414 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -63.23 -36.52 83.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.72 -42.3 92.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.978 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -61.25 -38.37 86.44 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.264 0.554 . . . . 0.0 109.525 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.03 -43.06 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.3 tt0 -62.48 -48.03 81.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -55.35 -41.86 73.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.743 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.03 -37.97 18.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -99.38 -9.15 23.85 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.2 9.54 42.52 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.589 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.19 113.27 56.7 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 117.177 0.489 . . . . 0.0 110.593 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.47 151.45 1.05 Allowed 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.897 1.731 . . . . 0.0 112.057 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.63 -17.47 29.73 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.496 2.13 . . . . 0.0 112.277 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -78.91 -12.24 60.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -104.02 -10.96 17.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.908 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -110.76 139.3 46.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.286 0.565 . . . . 0.0 111.841 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -127.47 134.45 49.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.37 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -108.8 124.5 50.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.08 142.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.458 0.647 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -149.95 145.43 26.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.19 37.86 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.83 13.93 42.21 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.412 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -119.78 141.51 49.41 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.071 0.935 . . . . 0.0 112.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -81.72 131.61 35.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.91 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.3 mt -76.0 131.61 39.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.004 0.431 . . . . 0.0 111.058 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.17 137.84 31.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.604 0.716 . . . . 0.0 111.782 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -63.56 139.41 58.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.38 -12.58 61.67 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -94.02 157.81 15.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 110.818 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.0 p -100.93 160.78 14.08 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.1 -40.98 87.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.754 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.4 t -46.1 -38.88 8.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.287 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -52.94 -44.35 66.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.9 m-85 -102.79 103.97 14.22 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.818 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' C ' HD22 ' A' ' 60' ' ' ASN . 0.1 OUTLIER -47.54 65.76 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -97.85 101.39 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -84.41 169.9 14.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 112.306 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.28 145.38 26.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.069 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 58.13 69.56 0.72 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.22 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.449 ' C ' HD22 ' A' ' 67' ' ' LEU . 49.4 m -103.05 127.31 50.35 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.005 0.431 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -103.73 151.21 23.29 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.377 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -98.4 121.98 41.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.24 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -106.79 110.47 22.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -107.9 141.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.639 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -101.37 175.94 5.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.48 . . . . 0.0 110.349 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -67.29 -41.01 86.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -83.96 77.34 9.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.256 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -56.6 -33.05 65.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.887 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.9 -141.29 48.16 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.758 0 CA-C-O 117.993 -1.448 . . . . 0.0 110.892 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 22.8 mp0 -115.99 160.26 20.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.2 pt -155.06 172.34 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.105 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-85 -112.13 137.81 49.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.649 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -115.82 128.74 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' NZ ' ' OG1' ' A' ' 12' ' ' THR . 57.8 mmtt -110.78 131.24 55.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.08 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -105.87 179.38 4.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.069 0.461 . . . . 0.0 110.343 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.97 -21.42 61.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -85.68 10.24 14.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.08 22.52 76.01 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.243 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -88.26 132.25 34.45 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' NZ ' ' A' ' 6' ' ' LYS . 92.1 m -116.6 123.84 48.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.16 141.67 43.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.6 p -95.81 137.96 34.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.293 0.568 . . . . 0.0 110.323 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.06 148.04 47.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -105.3 121.23 43.43 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.61 163.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 111.705 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 19.9 mt-10 -98.19 149.82 36.11 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.62 -14.49 40.19 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.96 1.774 . . . . 0.0 111.518 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.93 8.92 30.83 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.449 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 18' ' ' GLU . 69.5 m-20 -64.6 147.3 53.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 110.117 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.9 p -89.35 149.53 22.97 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.907 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.13 -22.65 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.76 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.64 -56.36 4.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.956 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -53.0 -42.36 65.52 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.82 -39.73 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.451 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -63.18 -38.77 92.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.15 90.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.06 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -63.51 -39.17 93.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.367 0.603 . . . . 0.0 109.556 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -67.71 -48.77 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.422 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' GLY . 23.8 tm0? -60.41 -44.85 95.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.905 0.383 . . . . 0.0 110.624 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -57.05 -41.37 78.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.804 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -86.35 -37.04 18.87 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -101.16 -7.71 22.89 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.67 8.64 41.06 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.681 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mm -88.51 113.72 56.66 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 117.251 0.526 . . . . 0.0 110.344 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -44.4 154.26 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.803 1.669 . . . . 0.0 111.961 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.62 -24.92 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.562 2.175 . . . . 0.0 112.456 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.21 -10.66 58.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -93.99 -10.13 34.61 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.08 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -129.09 157.8 40.74 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.441 0.638 . . . . 0.0 112.024 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.07 139.54 48.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.554 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -109.76 128.25 55.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.67 144.43 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.329 0.585 . . . . 0.0 111.43 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -152.66 147.67 26.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.774 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.21 34.56 8.83 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.318 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 7.92 29.7 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.343 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -116.04 140.82 48.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.87 0.835 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.08 132.73 36.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.946 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.0 mt -74.93 126.43 30.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.22 139.38 30.54 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.801 0.81 . . . . 0.0 111.864 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.7 134.9 55.2 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.429 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.68 -12.65 53.78 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -97.9 156.72 16.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.421 0.61 . . . . 0.0 110.597 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -99.02 164.18 12.28 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -60.77 -41.15 94.93 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.624 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -48.49 -36.05 14.34 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.594 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.32 -43.2 78.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 61' ' ' ILE . 82.7 m-85 -102.79 105.75 16.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.473 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -46.98 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.35 99.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -84.69 171.42 12.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 112.408 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.27 146.2 40.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.906 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.44 69.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.999 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.5 m -98.53 121.77 40.89 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.704 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.2 mm? -98.61 145.69 26.59 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -95.91 121.86 38.09 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -111.63 110.19 20.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.499 ' N ' HD23 ' A' ' 69' ' ' LEU . 11.0 m -119.11 150.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.032 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 71' ' ' LEU . 7.7 mt -66.75 -175.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.866 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 73' ' ' LEU . 16.9 ptm180 -56.5 -24.62 47.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.265 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 72' ' ' ARG . 5.2 mp 47.12 -175.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.025 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 46.47 83.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.14 -137.7 2.57 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 118.046 -1.419 . . . . 0.0 110.94 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.02 149.79 36.88 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -150.63 169.32 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.137 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -112.68 142.46 45.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -117.49 127.5 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -108.48 132.48 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.7 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -107.38 -178.9 3.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.92 -24.0 61.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 9.17 9.77 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.22 75.76 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -118.53 124.34 47.29 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 pt -135.01 143.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.985 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.517 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.2 m -96.64 137.54 35.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 14' ' ' THR . 4.7 mp -124.69 148.66 47.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 8.1 pt-20 -104.71 122.12 45.01 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -144.46 163.03 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.581 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -103.12 135.75 19.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.034 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -47.66 -21.21 2.19 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.86 1.707 . . . . 0.0 111.819 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -95.25 7.28 46.63 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.827 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -69.16 145.15 53.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -89.78 152.83 21.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.62 -21.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.751 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -76.04 -57.49 3.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.113 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -53.89 -41.24 67.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.471 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.94 -40.5 87.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.583 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -62.49 -39.2 92.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.37 86.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.035 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 95.8 mttt -64.66 -40.36 95.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.2 -45.81 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.2 tt0 -60.92 -45.86 92.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.02 -38.98 73.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.754 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -86.82 -37.37 17.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -101.9 -8.44 21.58 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.71 11.5 36.53 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.511 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.33 114.21 59.46 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.206 0.503 . . . . 0.0 110.41 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -45.34 144.86 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.925 1.75 . . . . 0.0 112.221 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.16 -20.77 28.01 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.483 2.122 . . . . 0.0 112.26 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -76.34 -14.17 60.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.677 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -103.94 -6.06 21.64 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.04 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.54 144.31 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.455 0.645 . . . . 0.0 111.972 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -129.07 134.49 48.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.359 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.0 mt -111.91 127.54 55.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.851 0.358 . . . . 0.0 110.704 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.48 144.01 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.38 0.609 . . . . 0.0 111.457 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -149.33 142.11 24.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.609 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.63 37.72 20.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.36 9.67 24.92 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.305 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -116.71 140.97 48.81 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.193 0.997 . . . . 0.0 111.841 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -80.3 133.46 35.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.257 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.46 125.93 30.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.928 0.394 . . . . 0.0 110.822 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -83.24 140.45 32.52 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.685 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.29 134.59 51.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.625 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.37 -9.63 59.28 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -96.03 158.8 15.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.285 0.543 . . . . 0.0 110.692 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.9 p -100.47 159.77 14.88 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.91 -39.26 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.032 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -47.0 -38.31 10.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.494 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -51.91 -42.7 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.683 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.6 m-85 -103.86 105.1 15.19 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.84 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -46.87 66.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.8 mt -99.87 101.48 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -86.36 173.04 9.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.462 0.649 . . . . 0.0 112.125 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -58.0 146.73 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.073 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 58.71 69.73 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.26 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -104.04 125.03 50.08 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -100.31 148.66 24.43 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.699 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.79 121.43 37.51 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.288 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.4 tt -109.16 105.95 15.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 69' ' ' LEU . 59.9 t -110.21 143.88 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.923 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 71' ' ' LEU . 7.9 mt -78.11 -175.65 4.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.43 -40.92 72.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.242 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.76 131.53 39.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.357 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -64.13 -42.06 96.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.65 164.41 34.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.725 0 CA-C-O 117.94 -1.478 . . . . 0.0 110.924 179.899 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 94.1 mt-30 -116.75 159.59 22.06 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.534 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.7 pt -154.65 171.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.097 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.22 139.43 46.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.722 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.31 128.95 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.28 132.67 54.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.711 -179.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -108.33 -178.35 3.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.96 0.41 . . . . 0.0 110.318 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tp -70.65 -29.8 66.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.959 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -77.31 9.35 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.068 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.49 24.28 75.15 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.74 132.99 34.37 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -117.0 124.08 48.45 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.64 141.39 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -94.92 137.96 33.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.01 146.7 47.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.076 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -105.57 122.01 45.14 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.45 165.53 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.283 0.563 . . . . 0.0 111.752 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -100.28 149.58 36.17 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 -13.72 38.17 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.824 1.683 . . . . 0.0 111.376 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -106.53 7.69 30.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.362 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.01 147.33 52.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -89.18 148.24 23.74 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 23' ' ' ILE . 2.0 mp -50.5 -23.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -76.57 -55.56 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.099 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 63.4 t-20 -53.64 -43.4 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.2 -41.82 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -60.74 -37.73 82.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -59.89 -37.97 80.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.095 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 63.3 mttp -64.32 -40.91 96.86 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.24 -47.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.248 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.5 tm0? -60.96 -45.12 96.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 110.572 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -55.81 -40.31 72.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.668 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.19 -36.55 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.12 -10.87 21.01 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.62 14.25 49.31 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.394 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.0 mt -91.98 134.41 28.8 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.243 0.521 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.09 121.54 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.524 1.482 . . . . 0.0 111.794 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -47.62 -16.05 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.698 2.265 . . . . 0.0 112.175 179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.06 -21.18 61.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.0 -4.9 22.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.105 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -115.47 144.82 43.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.403 0.62 . . . . 0.0 112.053 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.0 mmt-85 -131.19 138.46 49.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.424 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.25 129.4 56.53 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 0.0 110.824 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.7 144.51 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.298 0.57 . . . . 0.0 111.193 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -147.85 142.34 26.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.874 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.42 39.32 20.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.548 0.69 . . . . 0.0 109.25 -179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 7.88 21.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.816 -1.084 . . . . 0.0 113.361 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.05 140.94 48.88 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.133 0.966 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 4.6 tm0? -80.35 133.41 35.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.113 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 12.7 mt -74.38 125.55 28.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.995 0.426 . . . . 0.0 110.925 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -83.5 151.16 25.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.546 0.689 . . . . 0.0 111.904 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -76.67 151.88 35.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.801 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.02 -9.64 62.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -98.15 161.48 13.69 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 15.4 p -102.57 161.47 13.7 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.01 -39.04 71.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.799 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 t -46.17 -35.62 5.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 55' ' ' THR . 14.4 m-20 -55.51 -46.49 76.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.69 ' O ' ' N ' ' A' ' 61' ' ' ILE . 65.9 m-85 -101.62 100.15 10.51 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.598 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.84 65.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' N ' ' O ' ' A' ' 59' ' ' TYR . 97.9 mt -97.01 101.93 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.39 176.25 7.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.37 0.605 . . . . 0.0 112.31 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -59.91 145.09 47.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.94 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 57.1 69.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.264 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.4 m -99.16 120.21 39.13 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.432 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp -100.12 144.68 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -95.8 123.05 39.21 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.271 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.95 116.29 30.36 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.07 152.39 36.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.965 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.87 -176.44 6.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.102 0.477 . . . . 0.0 110.692 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -77.01 -56.41 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.3 -15.38 53.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.999 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 54.31 87.76 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.12 -67.68 0.08 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.026 -0.829 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.006 -1.441 . . . . 0.0 110.954 179.989 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 3' ' ' ILE . 77.5 mt-30 -116.01 159.02 22.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -155.18 172.14 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.105 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.36 140.49 47.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.777 -179.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.32 128.23 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -109.27 131.3 55.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.762 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -108.19 -179.12 3.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.015 0.436 . . . . 0.0 110.369 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.2 tp -69.85 -31.4 69.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.869 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 p -74.78 8.86 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.98 -179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.41 74.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -90.8 135.06 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -117.97 125.77 51.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 tt -132.48 142.42 42.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.173 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD12 ' A' ' 15' ' ' LEU . 11.5 m -98.42 137.02 37.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.623 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 14' ' ' THR . 3.9 mp -125.61 150.42 47.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.96 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -105.87 123.26 47.69 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 1.2 m -145.94 165.45 9.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.218 0.533 . . . . 0.0 111.594 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 61.0 mt-10 -105.21 148.06 35.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.93 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.28 -21.12 42.38 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.886 1.724 . . . . 0.0 111.836 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -97.07 5.31 50.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.721 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 73.0 m-20 -65.83 146.53 54.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.0 p -89.99 149.75 22.42 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.956 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 10.8 mm -53.51 -22.31 5.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.836 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -75.8 -56.0 5.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.133 179.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -55.15 -41.02 71.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.772 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.91 -39.79 85.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.524 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 39.3 mttp -62.52 -38.26 89.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.94 83.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.085 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 17' ' ' VAL . 79.5 mttt -63.99 -40.46 96.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.311 0.577 . . . . 0.0 109.735 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.55 -44.91 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.179 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.8 tt0 -61.72 -45.62 93.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.05 0.452 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -56.43 -39.61 73.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.766 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -88.79 -35.87 16.41 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -99.26 -11.07 21.61 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.45 11.42 52.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.664 178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.78 133.65 27.56 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.194 0.497 . . . . 0.0 110.151 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 150.69 58.67 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.862 1.708 . . . . 0.0 112.05 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.43 -14.14 33.68 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.586 2.191 . . . . 0.0 112.373 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' OD1' ' NH1' ' A' ' 72' ' ' ARG . 13.0 t70 -75.64 -19.81 58.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.785 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -105.35 -8.49 18.17 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.072 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -114.5 144.46 43.32 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.373 0.606 . . . . 0.0 112.144 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 138.08 49.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.36 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 mt -112.57 130.21 56.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 110.909 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.11 144.53 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.405 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -151.18 144.12 24.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.564 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.4 36.21 19.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.69 8.25 19.87 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.446 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.03 141.58 47.8 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.962 0.881 . . . . 0.0 111.869 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.16 133.38 35.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.957 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.32 133.05 36.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.037 0.446 . . . . 0.0 111.082 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -94.42 141.62 28.37 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.707 0.765 . . . . 0.0 111.647 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -66.24 138.59 57.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.434 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.61 -13.43 59.53 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -96.81 160.62 14.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.217 0.508 . . . . 0.0 110.712 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -102.06 161.68 13.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.73 -39.09 83.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.871 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -45.67 -39.34 7.77 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.598 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -53.76 -43.21 68.98 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.686 ' O ' ' N ' ' A' ' 61' ' ' ILE . 68.7 m-85 -102.53 101.92 12.13 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.464 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -47.33 65.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -97.5 101.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -86.46 172.29 10.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.89 146.53 37.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.114 -178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 58.93 68.42 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.656 -1.156 . . . . 0.0 112.068 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -100.3 122.74 43.57 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.28 144.83 26.68 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -93.82 119.86 33.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.23 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.8 111.8 23.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.68 150.05 27.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.789 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.62 -177.23 6.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.756 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' NH1' ' OD1' ' A' ' 39' ' ' ASP . 36.8 ttm180 -70.83 -38.79 73.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.41 130.95 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -71.37 120.59 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.479 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.54 16.03 80.88 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.077 -1.401 . . . . 0.0 110.872 179.926 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.14 143.49 43.09 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.582 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.8 164.25 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.846 179.088 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -109.44 140.24 43.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.78 129.31 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -112.16 133.44 54.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.784 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -109.67 -176.32 2.98 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.335 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -69.2 -35.53 76.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -72.38 9.16 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.847 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.46 28.73 73.64 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -89.63 132.95 34.87 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -116.56 124.93 51.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.71 143.79 36.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.307 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -101.7 140.75 35.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.45 151.98 47.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.977 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.79 124.18 49.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.58 168.14 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 0.0 111.593 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -101.28 150.6 37.3 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.78 -15.95 52.84 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.943 1.762 . . . . 0.0 111.539 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -101.7 5.94 41.63 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.477 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -65.87 147.61 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.256 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -89.79 151.33 21.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -51.71 -22.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.354 -0.539 . . . . 0.0 109.74 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.72 -54.02 6.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.98 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -55.52 -43.07 75.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.499 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.87 -41.19 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.382 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -62.71 -38.17 89.4 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.18 87.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.128 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.01 -39.05 92.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 109.542 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.629 HG21 HE22 ' A' ' 41' ' ' GLN . 75.9 mt -67.05 -44.7 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.345 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.1 tt0 -61.1 -45.48 94.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.891 0.377 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -56.12 -38.28 70.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.455 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.47 -38.21 13.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -99.41 -12.1 20.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.06 10.39 59.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.007 -0.615 . . . . 0.0 112.66 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -82.87 131.08 55.39 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.165 0.483 . . . . 0.0 110.307 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -76.22 125.13 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.796 1.664 . . . . 0.0 112.228 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -42.9 -16.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.505 2.137 . . . . 0.0 112.529 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 37' ' ' PRO . 90.5 m-20 -76.64 -24.41 53.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.149 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.73 -11.01 15.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.064 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.629 HE22 HG21 ' A' ' 30' ' ' ILE . 25.3 tt0 -100.92 133.54 45.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.351 0.596 . . . . 0.0 112.081 -178.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -125.99 130.66 51.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.68 130.38 56.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.66 0.267 . . . . 0.0 110.769 -179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.4 mt -129.9 146.35 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.339 0.59 . . . . 0.0 111.269 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -151.75 148.31 27.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.81 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.09 34.83 6.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.03 36.11 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.406 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -117.86 140.84 49.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.026 0.913 . . . . 0.0 112.003 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -79.39 133.14 36.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -74.1 125.09 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.022 0.439 . . . . 0.0 111.1 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -87.13 140.1 29.89 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.637 0.732 . . . . 0.0 111.625 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.86 136.43 55.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.685 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.25 -12.9 58.69 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -95.81 157.67 15.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.276 0.538 . . . . 0.0 110.713 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -99.26 161.32 13.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.57 -41.3 89.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.798 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -46.57 -35.87 6.27 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.359 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.46 -43.59 68.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.672 ' O ' ' N ' ' A' ' 61' ' ' ILE . 78.7 m-85 -105.93 103.54 13.05 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.592 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -47.5 66.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.8 mt -96.09 100.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -83.73 169.42 15.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 112.386 -178.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -57.65 147.73 26.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.99 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.59 69.1 0.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.115 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 53.7 m -99.8 124.56 45.21 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.713 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -99.62 148.49 24.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.662 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -96.63 121.41 38.43 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.311 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.0 tt -107.23 106.83 17.49 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.89 138.88 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.963 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 71' ' ' LEU . 6.2 mt -78.6 -175.68 4.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.591 -179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -61.76 -38.14 86.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.2 mp -61.99 143.56 56.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.049 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.52 129.12 38.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 53.98 -102.98 0.14 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.005 -1.442 . . . . 0.0 110.9 -179.832 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' O ' HG23 ' A' ' 3' ' ' ILE . 17.0 pt20 -116.02 157.33 24.8 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.556 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.6 pt -155.17 171.78 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.121 178.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -112.94 140.24 47.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.617 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.32 126.77 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.67 132.01 54.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.644 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.6 p -108.31 -179.34 3.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.017 0.437 . . . . 0.0 110.282 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.5 tp -70.17 -27.35 64.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.962 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -79.12 9.2 4.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.885 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 23.41 75.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -88.66 132.94 34.36 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -116.62 124.09 48.93 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.86 142.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.182 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 m -97.63 135.15 39.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -122.76 147.42 46.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.041 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -105.71 121.79 44.73 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.49 166.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.33 0.586 . . . . 0.0 111.605 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -98.02 151.57 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.828 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.7 -11.25 31.12 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.99 1.793 . . . . 0.0 111.422 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 m -109.26 8.14 25.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.443 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.6 147.06 52.49 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.155 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 p -89.79 150.14 22.39 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mm -51.92 -23.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.419 -0.513 . . . . 0.0 109.723 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -75.45 -55.83 5.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.094 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -54.98 -41.68 71.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.527 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.91 -39.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.452 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -63.89 -38.2 90.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.38 78.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.141 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -64.29 -41.63 96.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.316 0.579 . . . . 0.0 109.741 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.0 mt -65.19 -48.01 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.382 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 35' ' ' GLY . 6.8 tt0 -59.63 -45.67 91.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.408 . . . . 0.0 110.523 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -57.86 -35.83 71.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.617 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -88.43 -38.35 15.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -105.02 -9.27 17.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 60.35 17.49 46.94 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.44 178.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -90.77 113.83 59.28 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 117.287 0.543 . . . . 0.0 110.468 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.95 120.3 2.85 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.746 1.63 . . . . 0.0 112.142 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.94 -28.52 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.629 2.219 . . . . 0.0 112.578 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -67.47 -16.15 64.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.189 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.59 -4.11 29.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.987 -179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -120.01 149.03 42.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.33 0.586 . . . . 0.0 112.029 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 135.86 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.286 178.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 44' ' ' ILE . 27.9 mt -105.44 122.33 45.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 -179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.1 mp -118.21 133.83 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.566 0.698 . . . . 0.0 111.254 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -144.38 138.72 27.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.701 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.14 37.92 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.38 8.71 26.7 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.451 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.18 141.79 47.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 117.998 0.899 . . . . 0.0 111.897 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.51 133.59 35.41 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.942 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.82 127.21 32.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.2 141.03 30.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.686 0.755 . . . . 0.0 111.593 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -65.59 136.66 56.64 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.624 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.03 -9.34 65.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -94.23 156.36 16.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.407 0.604 . . . . 0.0 110.722 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -99.91 160.07 14.59 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.25 -40.35 85.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.882 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -47.39 -37.21 10.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.385 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.58 -41.8 66.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' N ' ' A' ' 61' ' ' ILE . 63.0 m-85 -105.43 101.18 10.73 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.538 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -47.81 66.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.9 mt -98.35 103.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -88.43 175.48 7.6 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 112.358 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -60.12 147.64 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.989 -178.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 58.03 68.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.1 m -101.93 122.08 43.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.055 0.455 . . . . 0.0 110.726 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.12 146.79 25.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.665 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -96.96 120.72 37.83 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 69' ' ' LEU . 3.4 tt -107.26 108.08 19.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' N ' HD23 ' A' ' 69' ' ' LEU . 74.5 t -106.62 140.11 25.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.587 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.23 171.02 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 0.0 110.391 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -60.67 -49.69 76.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 73' ' ' LEU . 1.3 tt 65.65 107.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.101 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' N ' HD23 ' A' ' 73' ' ' LEU . 81.1 mtp180 -70.18 131.93 45.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.793 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.68 73.85 0.61 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.762 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.933 -179.883 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -114.47 149.27 36.58 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -153.21 169.02 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.115 178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.94 142.15 45.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.67 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.29 130.28 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -109.67 131.76 54.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.79 -178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -107.91 -178.14 3.53 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.174 0.511 . . . . 0.0 110.194 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.1 -32.08 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.929 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 p -76.27 10.25 2.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.971 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.67 25.47 73.99 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 2.8 ttmp? -86.24 132.23 34.04 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -117.62 122.41 43.52 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 pt -134.12 144.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.249 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -96.13 135.39 38.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.406 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.08 146.46 48.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.861 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.77 122.0 45.18 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.29 162.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.105 0.478 . . . . 0.0 111.657 -178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -94.4 151.58 39.48 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.036 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.63 -11.87 33.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.882 1.721 . . . . 0.0 111.462 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.2 t -108.5 10.48 27.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.36 -178.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -68.25 146.0 53.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -89.21 151.75 21.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -52.72 -21.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.928 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -76.22 -56.71 4.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -55.38 -41.12 72.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.579 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -40.73 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.578 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -62.62 -37.06 84.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.88 82.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.135 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.89 -41.41 95.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.374 0.607 . . . . 0.0 109.561 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.18 -48.26 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.462 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 51.0 tt0 -59.3 -45.3 91.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.578 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -56.96 -38.9 73.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -88.06 -38.05 15.77 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -99.93 -9.51 22.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 62.35 15.69 52.49 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.819 178.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.07 113.01 61.39 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 117.144 0.472 . . . . 0.0 110.706 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.84 147.91 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.805 1.67 . . . . 0.0 112.219 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.55 -16.18 30.56 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.42 2.08 . . . . 0.0 112.27 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -77.99 -14.99 59.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -103.76 -7.04 20.89 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.891 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -121.71 148.9 44.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.428 0.632 . . . . 0.0 111.8 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -131.88 139.49 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.472 178.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.89 127.53 55.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.78 0.324 . . . . 0.0 110.636 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -126.52 143.27 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.424 0.63 . . . . 0.0 111.48 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -147.26 140.37 25.2 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.732 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.14 40.04 27.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.284 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.69 9.13 11.74 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.384 179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -115.56 141.66 47.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.134 0.967 . . . . 0.0 111.685 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -81.02 132.45 35.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.66 126.85 31.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.863 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -84.62 140.73 31.16 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 111.738 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.66 134.38 54.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.628 179.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 -8.01 60.02 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -94.84 155.58 16.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.29 0.545 . . . . 0.0 110.68 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.533 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 46.9 p -99.12 158.46 15.66 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.84 -40.55 76.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.0 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.1 p -45.92 -36.68 5.62 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 55' ' ' THR . 36.7 m-20 -55.92 -45.03 78.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.5 m-85 -99.4 99.65 10.59 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.758 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -48.32 63.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -177.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.5 mt -98.02 101.2 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.8 174.53 10.88 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.487 0.661 . . . . 0.0 112.145 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.02 147.84 37.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.05 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 57.41 66.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.984 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.8 m -101.97 126.11 48.81 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 33.7 tp -100.45 147.6 25.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.77 121.6 39.88 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.456 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.07 111.22 22.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 t -110.32 143.56 20.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.605 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.15 170.59 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.207 0.527 . . . . 0.0 110.467 -179.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt85 -86.51 -50.12 7.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.322 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -160.12 178.3 9.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -157.32 161.84 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.576 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.41 -77.02 0.15 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.966 -1.463 . . . . 0.0 110.841 -179.966 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -117.55 158.64 24.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -154.56 173.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.171 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -113.14 139.14 48.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.664 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.63 123.32 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -106.49 131.84 53.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.689 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -106.94 179.96 4.11 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.048 0.452 . . . . 0.0 110.289 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.8 tp -71.27 -24.22 62.12 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 p -82.03 9.79 7.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.762 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.27 23.78 76.21 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -88.23 134.04 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m -118.02 122.72 43.91 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.81 143.95 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.183 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -99.07 135.97 39.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mp -124.23 147.56 47.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.0 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -103.48 120.77 41.49 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.68 164.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.245 0.545 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -98.91 151.87 37.57 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.924 179.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.04 -11.69 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.897 1.732 . . . . 0.0 111.462 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -107.55 7.52 28.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.37 146.72 54.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -89.56 150.64 22.33 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.941 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.65 -21.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.758 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -75.58 -56.63 4.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.143 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -55.61 -41.41 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.513 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.34 -37.17 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.527 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -65.33 -38.91 91.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.75 75.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.922 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.37 -39.8 92.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.362 0.601 . . . . 0.0 109.382 178.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.27 -45.8 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.231 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 57.2 tt0 -60.31 -45.93 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.93 -37.61 71.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.692 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.68 -39.34 13.26 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.56 -11.66 21.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 61.33 15.2 44.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.664 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.0 mm -94.3 113.5 60.97 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.156 0.478 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -45.12 121.03 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.742 1.628 . . . . 0.0 112.069 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.87 -24.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.57 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.28 -17.98 65.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.225 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.434 HE22 ' HE ' ' A' ' 72' ' ' ARG . 25.1 mm100 -103.96 -4.93 22.75 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.972 -179.45 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -114.18 144.37 43.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.345 0.593 . . . . 0.0 111.972 -178.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -130.02 135.9 48.8 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 44' ' ' ILE . 23.0 mt -108.86 126.82 53.46 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.776 0.322 . . . . 0.0 110.875 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.7 mp -123.74 137.74 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.573 0.701 . . . . 0.0 111.394 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -143.01 135.18 27.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.824 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 39.87 27.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.18 9.73 37.13 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.34 138.94 51.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.143 0.972 . . . . 0.0 111.769 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 50' ' ' LEU . 12.0 tm0? -82.48 133.42 35.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.905 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 16.0 mt -74.31 126.0 29.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.43 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.1 139.21 31.9 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.67 0.748 . . . . 0.0 111.553 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.35 133.45 52.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.759 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.79 -11.34 56.18 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -95.48 156.22 16.42 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.324 0.562 . . . . 0.0 110.685 179.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.6 p -100.01 160.43 14.32 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' TYR . 8.3 mp -56.81 -41.14 77.23 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.795 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.2 t -47.98 -37.25 14.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.276 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.52 -43.61 75.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 61' ' ' ILE . 96.1 m-85 -103.68 102.36 12.21 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.725 179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -46.54 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -99.45 98.84 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -86.36 176.11 8.07 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 112.191 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -59.6 145.04 45.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.048 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 58.25 69.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.223 179.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.7 m -98.98 122.95 42.91 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 67' ' ' LEU . 4.4 mm? -97.93 143.82 28.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.701 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -96.17 120.2 36.03 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.129 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.5 tt -107.17 108.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 69' ' ' LEU . 21.5 t -110.26 143.28 20.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.717 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -92.48 174.45 7.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.57 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HE ' HE22 ' A' ' 40' ' ' GLN . 71.7 ttp85 -54.9 -52.55 62.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.35 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' O ' HD21 ' A' ' 71' ' ' LEU . 57.2 tp -71.74 136.03 47.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.257 179.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -148.82 156.92 43.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.62 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.49 -178.55 53.64 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.924 -1.486 . . . . 0.0 110.812 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' ILE . 96.3 mt-30 -116.04 160.1 20.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 110.503 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.3 pt -156.44 173.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.206 178.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -113.84 140.66 48.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.536 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.67 125.0 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -106.55 129.44 54.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.549 -178.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -105.89 -178.26 3.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.996 0.427 . . . . 0.0 110.457 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.96 -29.79 66.99 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.891 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -77.59 10.71 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.789 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.22 73.44 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -87.61 134.99 33.54 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -116.79 122.41 44.35 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.73 143.12 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.063 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -99.13 135.67 40.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.6 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.97 147.45 47.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.925 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -104.34 121.89 44.3 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.58 166.57 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.304 0.573 . . . . 0.0 111.518 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -103.43 150.37 37.94 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.761 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.04 -17.19 58.93 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.968 1.779 . . . . 0.0 111.472 -179.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.5 p -100.51 6.18 44.24 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -65.32 145.9 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.6 p -91.96 152.63 19.93 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -52.51 -21.95 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.49 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.02 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 4.0 t-20 -53.11 -43.33 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.83 -39.21 84.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.365 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -62.46 -39.27 92.86 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.0 81.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 60.6 mttp -64.68 -44.34 90.65 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.374 0.607 . . . . 0.0 109.702 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.565 ' CG2' HE22 ' A' ' 41' ' ' GLN . 95.9 mt -64.53 -46.2 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 35' ' ' GLY . 17.0 tt0 -59.53 -47.63 84.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.0 -35.31 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.7 -179.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.36 -40.58 10.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.7 -12.55 18.29 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.68 10.5 67.39 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.571 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.03 128.37 56.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 117.296 0.548 . . . . 0.0 110.302 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.81 156.85 39.53 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.85 1.7 . . . . 0.0 112.108 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' HE21 ' A' ' 31' ' ' GLN . 70.8 Cg_endo -69.4 -14.04 36.59 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.495 2.13 . . . . 0.0 112.343 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -80.28 -21.21 42.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -109.95 -13.75 14.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.53 0.205 . . . . 0.0 110.911 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.565 HE22 ' CG2' ' A' ' 30' ' ' ILE . 17.5 tt0 -104.05 136.07 44.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.308 0.575 . . . . 0.0 111.841 -178.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -127.31 134.38 50.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.505 178.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.96 131.29 56.98 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.718 0.294 . . . . 0.0 110.647 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.78 142.67 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 111.267 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -145.55 138.76 26.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.692 179.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.93 39.14 28.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.071 -179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.13 8.77 18.93 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 113.479 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.53 140.57 48.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 117.982 0.891 . . . . 0.0 111.811 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -79.81 133.78 36.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.985 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.46 127.47 32.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -87.18 141.79 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.683 0.754 . . . . 0.0 111.476 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.98 140.06 58.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.823 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.03 -9.93 72.33 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -94.28 155.69 16.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.234 0.517 . . . . 0.0 110.751 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -96.44 159.52 14.9 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.26 -39.62 83.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.756 179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -46.98 -34.35 5.5 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.152 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -54.95 -44.3 74.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 61' ' ' ILE . 76.0 m-85 -104.75 102.31 11.88 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.585 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -45.87 68.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 59' ' ' TYR . 87.8 mt -98.35 98.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -86.16 175.16 8.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.319 0.581 . . . . 0.0 112.355 -178.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.84 144.57 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.924 -179.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 57.3 68.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.917 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -103.09 120.13 40.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.2 tp -96.92 145.95 25.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.771 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -95.86 120.81 36.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.409 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.6 tt -108.96 108.0 18.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' N ' HD23 ' A' ' 69' ' ' LEU . 20.5 t -111.42 144.87 18.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.607 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.87 162.12 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 110.417 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -85.89 -62.08 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.069 179.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.3 mt -107.74 145.46 33.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.224 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mmt-85 -55.94 -36.62 67.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.747 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.74 132.97 1.52 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.695 0 CA-C-O 117.952 -1.471 . . . . 0.0 111.01 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -115.91 153.95 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.543 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.75 169.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.009 178.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 30.7 m-85 -111.57 139.87 46.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.552 -179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.51 127.3 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -109.79 131.65 54.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.646 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -106.02 179.17 4.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.034 0.445 . . . . 0.0 110.349 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.3 mp -72.5 -16.85 61.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.689 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -87.99 9.59 21.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.982 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.12 22.55 76.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' NZ ' ' CG2' ' A' ' 13' ' ' ILE . 61.4 tttm -90.27 133.17 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -117.98 124.88 49.27 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' CG2' ' NZ ' ' A' ' 11' ' ' LYS . 22.0 pt -135.08 143.64 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.201 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -96.11 137.4 35.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.471 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -121.47 143.04 49.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.024 -179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 9.1 mp0 -103.1 120.67 41.11 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.205 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.51 166.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.132 0.491 . . . . 0.0 111.625 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -98.96 151.51 37.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 -15.5 50.85 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.912 1.741 . . . . 0.0 111.58 -179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -103.28 9.14 38.21 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.509 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -68.35 144.54 54.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.6 p -89.42 152.0 21.72 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.088 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.9 mm -51.9 -22.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.7 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' OD2' ' A' ' 52' ' ' ASP . 19.4 mm-40 -76.93 -54.02 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.982 179.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.74 -41.33 77.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.08 -38.61 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 23.4 mttp -64.42 -38.44 91.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.42 79.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.097 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.86 -40.07 95.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.399 0.618 . . . . 0.0 109.526 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.26 -47.45 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.5 tt0 -59.27 -45.9 89.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.008 0.433 . . . . 0.0 110.602 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -57.12 -39.09 74.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.711 -178.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -86.13 -38.05 18.14 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.62 -7.88 21.42 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.46 17.23 59.53 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.567 178.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -96.72 110.27 52.46 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.236 0.518 . . . . 0.0 110.376 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.88 149.44 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.894 1.729 . . . . 0.0 112.175 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.28 -15.95 35.27 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.591 2.194 . . . . 0.0 112.227 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.4 -17.81 61.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.901 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -108.5 -7.93 15.65 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.994 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.16 137.66 42.59 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.553 . . . . 0.0 112.251 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.3 mmm-85 -131.76 139.06 48.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.433 178.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 mt -119.64 132.78 55.77 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.673 0.273 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.29 144.36 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.312 0.577 . . . . 0.0 111.32 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -149.15 143.24 25.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.733 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.12 38.11 23.37 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.248 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.56 10.61 24.54 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.782 -1.099 . . . . 0.0 113.46 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -117.37 142.06 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.092 0.946 . . . . 0.0 111.835 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' NE2' HH11 ' A' ' 42' ' ' ARG . 94.7 mt-30 -81.38 132.73 35.34 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.004 178.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.43 127.45 32.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.894 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -84.59 140.68 31.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.691 0.758 . . . . 0.0 111.766 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' OD2' ' OE2' ' A' ' 24' ' ' GLU . 5.4 m-20 -66.55 133.28 50.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.481 179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.45 53.9 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -94.71 157.78 15.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.328 0.564 . . . . 0.0 110.751 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -101.0 160.15 14.61 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' TYR . 7.1 mp -58.96 -41.15 86.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 119.976 -0.689 . . . . 0.0 109.766 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -49.74 -37.45 29.52 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.436 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -54.66 -42.63 71.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 61' ' ' ILE . 81.4 m-85 -102.24 106.39 17.21 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.768 179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.85 62.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 59' ' ' TYR . 94.3 mt -100.63 100.1 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -87.13 174.24 8.76 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.306 0.574 . . . . 0.0 112.144 -178.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -59.83 148.42 34.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.148 -178.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 57.88 68.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.149 179.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.412 ' C ' HD22 ' A' ' 67' ' ' LEU . 96.4 m -97.37 121.98 39.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.645 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 67' ' ' LEU . 4.3 mm? -100.66 147.38 26.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.68 119.72 34.68 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.066 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 69' ' ' LEU . 5.3 tt -108.97 109.94 21.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 69' ' ' LEU . 14.8 p -126.29 151.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.881 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 71' ' ' LEU . 8.0 mt -78.8 -178.07 5.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -77.73 -41.33 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.227 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 tp 57.11 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.01 -40.44 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.45 18.86 72.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.013 -1.437 . . . . 0.0 110.954 -179.893 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -117.32 157.88 25.34 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.985 0.422 . . . . 0.0 110.46 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.42 171.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.04 178.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -112.57 138.17 49.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.807 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -117.7 129.9 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -111.33 132.44 54.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.665 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -108.09 -178.57 3.65 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.58 -28.55 64.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.065 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -79.22 9.17 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.7 25.82 74.86 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -88.89 133.1 34.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.6 m -118.52 123.67 45.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.78 143.05 38.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.094 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -95.63 138.02 33.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.69 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mp -124.72 146.98 48.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.896 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 5.8 pt-20 -108.03 123.6 48.91 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.89 165.98 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 111.545 -179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -98.62 149.03 35.35 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.802 178.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.46 -12.83 35.19 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.007 1.805 . . . . 0.0 111.567 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.9 t -104.57 6.8 34.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.27 -179.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.92 147.04 53.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 110.265 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -89.69 151.48 21.84 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.0 mm -53.44 -20.85 3.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.826 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -76.7 -55.68 5.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.45 -43.15 75.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.0 t -64.45 -41.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.583 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -62.71 -37.49 86.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.0 78.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.134 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' GLU . 89.7 mttt -66.14 -40.42 90.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.306 0.574 . . . . 0.0 109.567 179.028 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.68 -47.17 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.419 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -60.45 -46.89 88.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.062 0.458 . . . . 0.0 110.642 -179.802 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -55.64 -37.42 68.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -89.27 -36.62 15.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.47 -11.0 20.53 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.11 13.17 61.65 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.678 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.0 mm -96.28 133.68 24.63 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 117.233 0.517 . . . . 0.0 110.483 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.5 150.56 51.85 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.801 1.667 . . . . 0.0 111.952 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.92 -14.08 37.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.593 2.195 . . . . 0.0 112.261 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.01 -18.5 58.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.997 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -106.03 -7.77 17.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.038 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -114.83 144.81 42.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.364 0.602 . . . . 0.0 111.943 -178.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -129.02 134.82 48.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.48 120.82 42.91 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -114.44 132.83 62.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-O 121.835 0.826 . . . . 0.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.81 136.76 27.46 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.75 38.36 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.06 9.83 36.91 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.332 179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -119.35 141.98 48.55 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.044 0.922 . . . . 0.0 111.967 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -83.61 135.14 34.72 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.46 132.5 37.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 0.0 111.001 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.87 141.27 29.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 111.655 -179.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.7 133.53 53.74 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.552 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.34 -10.19 57.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -92.58 156.17 17.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.344 0.572 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -101.28 157.95 16.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -57.49 -40.57 78.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.845 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -48.32 -36.33 14.09 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.368 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.78 -42.96 68.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' O ' ' N ' ' A' ' 61' ' ' ILE . 85.0 m-85 -104.42 102.66 12.31 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.549 179.149 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -47.68 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.7 mt -98.16 102.53 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -87.23 176.44 7.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.401 0.619 . . . . 0.0 112.405 -178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -59.1 145.34 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.017 -178.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 58.43 69.39 0.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.34 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.19 121.82 42.53 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.983 0.42 . . . . 0.0 110.681 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.7 tp -103.36 146.64 28.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -100.42 124.1 45.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.306 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 69' ' ' LEU . 6.2 tt -106.82 108.98 20.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.61 142.11 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.842 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -119.53 170.4 9.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.117 0.484 . . . . 0.0 110.408 -179.723 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -62.06 -16.27 50.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.355 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER 70.77 37.86 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.6 91.36 7.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.424 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.47 161.21 25.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.95 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 3' ' ' ILE . 14.4 pt20 -117.67 158.01 25.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.48 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' GLN . 1.4 pt -155.97 172.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 29.7 m-85 -108.37 138.1 45.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.539 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.88 122.48 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -107.19 129.47 54.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.652 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -105.5 -179.93 4.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.967 0.413 . . . . 0.0 110.299 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.74 -14.44 61.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.764 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -90.44 10.29 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.66 22.31 75.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -88.11 133.84 33.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -117.98 122.8 44.17 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.98 144.04 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.347 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.28 136.18 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 140.79 49.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.075 -179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -105.31 119.8 39.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -146.57 167.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.206 0.527 . . . . 0.0 111.861 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.62 149.38 35.68 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.85 -13.63 38.26 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.967 1.778 . . . . 0.0 111.61 -179.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -106.09 8.57 32.3 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -67.04 146.86 53.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -88.37 149.65 23.62 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.07 -23.04 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.883 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -73.64 -57.88 3.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.041 179.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 53.1 t30 -53.33 -44.0 68.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.681 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.5 -41.13 90.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.913 0.387 . . . . 0.0 110.38 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.01 -37.93 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.203 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.79 -37.63 76.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.035 179.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -62.92 -39.79 95.65 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.422 0.629 . . . . 0.0 109.542 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.29 -42.8 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.418 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.9 tt0 -62.45 -47.45 83.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.918 0.389 . . . . 0.0 110.568 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.42 -37.54 67.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.68 -178.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.4 -40.04 13.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.25 0.834 . . . . 0.0 113.25 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -100.1 -12.15 19.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 63.16 11.12 37.5 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.48 178.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -87.08 115.03 61.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 117.252 0.526 . . . . 0.0 110.286 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.75 121.99 3.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.62 1.547 . . . . 0.0 112.089 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.81 -34.97 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.552 2.168 . . . . 0.0 112.844 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -62.2 -11.0 12.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.064 -179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -105.04 -9.37 17.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.043 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -114.27 143.75 44.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.292 0.567 . . . . 0.0 111.844 -178.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -130.5 137.46 49.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.1 mt -110.49 127.84 55.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mt -125.74 143.29 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.288 0.566 . . . . 0.0 111.385 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -149.43 143.03 25.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.605 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.86 37.4 17.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.318 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.66 8.57 27.6 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.379 178.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -115.88 141.2 48.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.992 0.896 . . . . 0.0 111.66 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -80.58 134.97 35.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.289 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -78.12 127.21 31.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 110.697 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.43 143.99 29.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.765 0.793 . . . . 0.0 111.908 -179.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -68.8 143.29 54.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.523 179.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.63 -9.51 76.86 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -94.04 157.8 15.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.257 0.528 . . . . 0.0 110.784 179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 p -98.72 159.41 14.97 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.86 -40.48 93.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.6 p -48.16 -35.19 11.2 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.321 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -55.22 -42.41 73.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 61' ' ' ILE . 97.2 m-85 -102.81 105.25 15.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -48.33 63.97 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.665 ' N ' ' O ' ' A' ' 59' ' ' TYR . 96.2 mt -97.05 103.36 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -86.56 171.13 11.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.444 0.64 . . . . 0.0 112.445 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -62.9 149.51 44.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.964 -178.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.56 65.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.056 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.6 m -96.14 121.88 38.39 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.679 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.7 145.14 26.05 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -95.59 120.6 36.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.21 111.5 23.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.4 t -121.04 148.31 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.972 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -72.4 -175.61 1.63 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.848 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -47.58 -34.0 7.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.8 mp -62.7 146.42 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -68.92 151.56 46.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.755 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.7 -33.76 35.04 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.765 0 CA-C-O 118.022 -1.432 . . . . 0.0 110.922 179.943 . . . . . . . . 0 0 . 1 stop_ save_